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ABSTRACT 
Severe sepsis kills an estimated 1,400 people worldwide every day. This often fatal 
infectious process accounts for an estimated 215,000 deaths in the United States (US) annually.  
The main goal of this project was to evaluate the impact of the Emergency Department 
Severe Sepsis Alert and Practice Protocol (EDSSAPP) post implementation, on time to first 
antibiotic administration, length of stay, and mortality in patients admitted via the ORMC ED 
with severe sepsis. 
This study evaluated the time to first antibiotic administration, total ED and hospital 
length of stay (LOS) and mortality of severe sepsis patients either with a severe sepsis alert 
(SSA) activated or no alert activated that were admitted to the hospital through the ED. A 
retrospective review of the electronic medical record (EMR) was conducted to gather the 
required data across three time cohorts: base line/time zero (T0), six months prior to the 
implementation of EDSSAPP; Time one (T1) the first six months following initial EDSSAPP 
implementation; and Time two (T2), six months following reinstatement of the corporate sepsis 
committee.  
The most significant finding of this study was the increased number of Severe Sepsis 
Alerts activated in time cohort T2 (n=113) compared to T1 (n=19). Another important finding 
was the decreased mortality in T2 (16.4%) compared to T0 (22.7%) and T1 (33%). Overall, the 
number of ED patients with severe sepsis who received antibiotics within the EDSSAPP required 
60 minutes did not consistently improve across the three time cohorts, T0 (81.8%), T1 (71.7%) 
and T2 (80.6%). 
The hospital LOS of stay was increased by almost 1.5 days between those patients with a 
severe sepsis alert activated in T1 (9.00 days) compared to time T2 (10.48 days). There was no 
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significant decrease in the ED LOS across time cohorts and between groups of patients who had 
a SSA activated versus no alert activated. However, there was a 1 hour and 28 minute decrease 
in ED LOS in patients who had a severe sepsis alert activated in T1 compared to T0. In addition, 
there was a 1 hour and 52 minutes decrease in ED LOS between patients who had a SSA 
activated compared to those who had no alert activated in T2. 
While EDSSAPP data does not demonstrate the statistically significant results that was 
expected, the challenges related to adherence by providers to EDSSAPP is as it is seen in the 
literature. Increased awareness via consistent communication of on-going audit results to ED 
personnel will heighten their awareness for severe sepsis and EDSSAPP. Improved collaborative 
efforts with the interdisciplinary team are needed to refocus everyone’s efforts to increase early 
recognition that is followed by appropriate treatment interventions and documentation is 
essential. Lastly, the development of a formal process to follow up with individual providers as 
close to real time as possible following a SSA that includes accountability for care provided and 
related documentation would also contribute to both awareness and adherence.  
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 CHAPTER ONE: INTRODUCTION 
Background/Scope of the Problem 
  Severe sepsis, commonly known as blood poisoning, is a serious health threat killing an 
estimated 1,400 people worldwide each day (http://ssc.sccm.org/background/worldsoldestkiller    
retrieved 7/4/12). Sepsis is the 10th leading cause of death in industrialized countries, killing as 
many people each year as does acute myocardial infarctions (Marshall, 2008). In addition, it is 
suspected that 80% of patients who died from major injuries actually succumbed from severe 
sepsis (http://ssc.sccm.org/background/worldsoldestkiller). Despite substantial research and 
significant advances in technology and treatment, severe sepsis continues to be deadly, with 
mortality rates ranging from 30 to 50% (Shorr, Micek, Jackson & Kollef, 2007). This fatal 
infectious process accounts for an estimated 215,000 deaths in the United States (US) annually 
(Rezende et al., 2008). From 1999 to 2005 approximately 6% of all US deaths were related to 
severe sepsis; however, it is important to note that secondary to documentation and reporting 
variances, the National Center for Health Statistics believes that this number may be grossly 
underestimated (Melamed & Sorvillo, 2009). Data from 2009 demonstrate that in the US alone, 
the economic and social burdens to society resulting from the direct costs of caring for the severe 
sepsis patient population is approximately $17 billion (Silva & Araujo, 2009). The indirect costs 
to society are thought to be somewhere between $34 and $51 billion annually As the US 
population continues to age, deaths from severe sepsis are only expected to increase (Melamed & 
Sorvillo, 2009). Severe sepsis was the leading cause of death for hospitalized patients in the US 
between 2003 and 2007 with the number of in-patient deaths increasing an alarming 35% and 
associated hospital costs increasing an estimated 57% (Lagu et al., 2012).  
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 The History and Definition of Severe Sepsis 
As early as 400 BC, Hippocrates described sepsis by saying that living tissue could be 
broken down in the body by one of two very different ways (Marshall, 2008). The first he called 
Pepsis; this was a healthy process, one that resulted in digestion of food and in nature caused the 
fermentation of grapes into wine. The second process he called Sepsis, where flesh becomes 
rotten and wounds festered. Hippocrates considered sepsis an evil process producing disease in 
man. In nature sepsis was thought to be responsible for the stench in swamps. These beliefs, as 
expressed by Hippocrates stood as one basis for understanding diseases for two thousand years. 
Another contribution to the understanding of sepsis was described by Galen of Pergamon (130 –
200 AD). Galen named the “cardinal signs of inflammation: rubor, calor, dolor and tumor” (p. 
471). Red, hot, and painful are today still considered the signs of an infectious process. A fifth 
symptom of inflammation, loss of function, was later added by Celsius. Hippocrates, Galen and 
Celsius’s conclusions remain foundational concepts regarding how diseases inflicted humans and 
caused life threatening physiological changes until the late 1800’s when the Pasteur Institute of 
France began the tedious task of exploring and understanding the complex microbial 
pathophysiology of infections.  
Despite the medical community’s growing knowledge of infectious diseases, there 
continues to be challenges encountered when caring for septic patients. Rather than addressing 
each patient’s unique immune response to the infectious process, the treatment for this patient 
population has continued to focus on ways to identify and kill the invading organisms. 
According to Warren (2010) “it isn’t the replication of bacteria in animals or humans that kills 
us, but rather the consequences related to the inflammatory response” (p.14). He goes on to 
describe the septic patient’s response to this process as a delicate balance between the patient not 
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 responding with enough inflammation to fight the invading microbes as in the immune-
compromised patient or in patients with a chronic infectious process. In contrast, Warren noted 
that the patient who experiences an excessive inflammatory response may rapidly advance into 
severe sepsis. Therefore, health is not only the lack of disease, but also regulation of the body’s 
inflammatory response to the presence of foreign organisms. The patient’s symptoms of sepsis 
are not initially caused by any injury or damage directly from the invading organisms, but rather 
the physiological response to the presence of organisms in the body. This conclusion supports 
the concept that, at least initially, the patient’s symptoms are a result of the invasion, and not 
widespread cellular damage from the offender.  This new perspective increases the opportunities 
for innovative treatment possibilities (Marshall, 2008). While the patient’s actual inflammatory 
response is responsible for symptoms of severe sepsis, identifying the exact initial cause or any 
contributing immune system compromise leading to the rapid advancement of the illness may 
not be easily identified.  
The Symptoms and Treatment of Severe Sepsis  
It is important to note that there is no one single organism responsible for severe sepsis. 
These infections may be caused by bacteria, viruses or fungi (Martin, Mannino, Eaton & Moss, 
2003). The symptoms of severe sepsis such as an altered mental status, tachycardia, fever, and 
hypotension are also seen in many other medical conditions; therefore caution must be taken in 
order to avoid misdiagnosis. Treating these patients by choosing the most effective antimicrobial 
medication to counteract the suspected cause of the illness is not a simple decision. Healthcare 
providers must, like a puzzle, analyze the symptoms and maintain a high index of suspicion for 
sepsis. The healthcare provider is also obligated to consider many additional treatment options 
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 and choose the interventions that they believe will achieve a positive outcome. On occasion, 
there are legitimate concerns that treatment decisions are made based on traditional approaches,   
rather than current evidence (Kollef &Micek, 2010). Treatment can be focused on reducing the 
patient’s systemic inflammatory response or may be aimed at killing the identified invading 
organism (Bone et al., 1992), or both. In 2005, the American Thoracic Society and the Infectious 
Disease Society of America collaborated to identify the most appropriate antimicrobial therapy 
for the treatment of nosocomial pneumonia. While choosing the appropriate antimicrobial may 
appear to be a simple concept, the recommending group believed there was clear evidence to the 
contrary based on evidence of poor patient outcomes. In addition to choosing the most 
appropriate antimicrobial agent, the timing of this treatment has also been determined to be an 
important key to the patient’s chance for survival. Every hour that passes without the 
administration of the appropriate antimicrobial mediation the patients chance of survival 
decreases 7.6%. 
Severe sepsis creates a wide variety of symptoms which can mimic many other medical 
conditions, making a definitive diagnosis and initiating treatment an ongoing challenge 
(Raghavan & Marik, 2006). In addition, each individual patient’s response to the invading 
microbes is also influenced by many contributing factors such as the patient’s age, the status of 
the immune system, and the presence of any pre-existing co-morbidities. There is however, no 
question that severe sepsis can lead to single or multiple organ dysfunction, multisystem organ 
failure, and death, and the number of lives lost secondary to sepsis can be reduced using the 
Surviving Sepsis Campaign (SSC) guidelines.  A worldwide campaign was launched to provide 
education and improve compliance with these guidelines for the treatment of sepsis. 
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 The Surviving Sepsis Campaign  
The established signs of inflammation, along with the understanding of microbes as 
causes of sickness, have remained basic fundamental theories of infections until the Barcelona 
Declaration in 2002. This conference resulted in increased attention to severe sepsis and spurred 
new interest and an increased the sense of urgency to learn more and find answers (Marshall, 
2008). At this international meeting of intensive care specialists, members of three of the world’s 
leading professional medical organizations – the European Society of Intensive Care Medicine, 
the Society of Critical Care Medicine (SCCM), and the International Sepsis Forum joined forces 
to work together to improve both the recognition and the treatment of severe sepsis. This united 
group of healthcare professionals acknowledged the costs to the world’s society were high both 
in the number of human lives lost and the corresponding societal financial burden. This group 
agreed that increased awareness by healthcare providers was an absolute necessity to achieve an 
early and accurate diagnosis of severe sepsis followed by the appropriate and timely treatment. 
The Barcelona Declaration had one simple yet ambitious primary objective: improve severe 
sepsis patient survival by 25% worldwide by 2009 (Rivers & Ahrens, 2008). The SSC was 
developed and the group elected to move forward in four phases.  
Phase one began in October of 2002 following the Barcelona Declaration. After both 
discussion and debate the group agreed that the universal definition of severe sepsis was the 
body’s systemic response to an overwhelming infection resulting in hypo-perfusion that can 
rapidly cause organ failure and death (Bone et al., 1992). The phase one goal was to globally 
communicate and educate by publishing the SSC components related to the importance of early 
recognition and treatment of severe sepsis.  
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 The SSC second phase began in 2003 when selected international experts in critical care 
and infectious disease collaborated to develop and publish severe sepsis treatment guidelines 
(http://www.survivingsepsis.org/guidelines/Pages/default.aspx). In early 2004 these guidelines 
were completed and recommended for adoption and implementation into clinical practice for this 
patient population. The guidelines were up-dated in 2008 and a summary of these guidelines are 
presented in Appendix A. While the SSC guidelines were again updated and released in the 
Spring of 2013 it is the 2008 guidelines that will be used for this study as these were the 
guidelines available during the inception and implementation of Emergency Department Severe 
Sepsis Alert and Practice Protocol (EDSSAPP) in the participating facility.  
The main objective of phase three was for the consortium promoting SSC to collaborate 
with the Institute for Healthcare Improvement (IHI), a not-for-profit independent organization 
whose main focus is helping leaders and healthcare providers worldwide to find ways to change 
the delivery of care in order to provide both safe and quality care to all who access the healthcare 
system (http://www.ihi.org/explore/Sepsis/Pages/default.aspx). Through this strategic 
partnership, sepsis bundles were developed using the evidence-based guidelines previously 
introduced in the SSC. A bundle consists of a group of evidence-based interventions that when 
implemented together can improve the patient’s outcomes. Bundles have become an important 
tool for health care providers. One important goal in developing the sepsis bundle was to make it 
user friendly and easy for providers to implement into their daily practice. The concept of Early 
Goal Directed Therapy (EGDT) was first described for the treatment severe sepsis and septic 
shock patients by Rivers et al. in 2001. Jones, Shapiro & Roshon, (2007) identified the unique 
challenges faced by ED’s in both community and academic medical facilities in implementing 
EGDT. This study noted that severe sepsis and septic shock had high mortality rates along with 
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 significant facility resource utilization. In addition, they concluded that early recognition 
combined with EGDT improved patient outcomes. EGDT in severe sepsis and septic shock is an 
important tool to improve patient outcomes and saves lives. The key to implementation of EGDT 
is dependent on the clinician’s ability to recognize the patient as having severe sepsis or septic 
shock. Part of this recognition includes evaluating the patient for specific criteria as defined in 
the SSC guidelines, such as a serum lactate greater than four, a systolic blood pressure less than 
90 mm Hg and a change in level of consciousness. According to Dellinger et al. (2008) early 
goal-directed resuscitation improves survival for emergency department patients presenting with 
septic shock.  
In addition, a central data collection process was developed by the SSC program 
(http://www.survivingsepsis.org/Data-Collection) so that participating facilities worldwide could 
enter information and results to determine if the SSC was making a difference and improving the 
care of severe sepsis patients. Tools were developed as a resource for users to produce graphs of 
their facilities’ data to help demonstrate their improvements 
(http://www.survivingsepsis.org/Resources/Pages/default.aspx). SSC guidelines and bundles 
were reviewed, revised and updated along with links provided on the websites where the most 
current sepsis information can be obtained. One link provided on the site is to the Advances in 
Sepsis (http://www.advancesinsepsis.com/) web site that has many of the current international 
leading medical experts as contributing authors.   
Phase four includes continuing to update the SSC program based on new evidence, as 
well as continuing the efforts to educate healthcare providers worldwide. In addition, an analysis 
of the data entered into the SSC website from 15,000 severe sepsis patient records was conducted 
and published: The Surviving Sepsis Campaign: Results of an international guideline-based 
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 performance improvement program targeting severe sepsis (Levy et al., 2010). This analysis 
validated results that patient outcomes were improved when SSC bundles were implemented. 
The Role of Evidence-Based Practice in the Treatment of Severe Sepsis 
Providing safe and quality patient care is a foundational principle for healthcare today 
and one important way to accomplish this is through the use of evidence-based practice (EBP). 
This term was first discussed in 1972 by the English medical researcher, Dr. Archie Cochran 
(Melnyk & Fineout-Overholt, 2011). Dr. Cochran strongly believed the best empirical evidence 
to support appropriate care came from randomized clinical trials. He further contended that there 
should be systematic and rigorous reviews of research in order to find the most effective 
treatments. It is important for healthcare providers today to combine EBP with sound clinical 
judgment and collaboration with the patient (Dontje, 2007). While there are still some healthcare 
providers who continue to feel that EBP is a “cookie cutter approach,” professional healthcare 
organizations have embraced it, issuing best practice guidelines based upon EBP principles.  
In addition, EBP has become an accreditation standard and incorporated into 
accreditation review by agencies such as The Joint Commission (TJC).  As an example, TJC 
establishes National Patient Safety Goals based on merit, cost and effectiveness.  These goals are 
promoted as an accreditation standard and enforced through the accreditation review process.  
Implementation of EBP requires interdisciplinary collaboration between healthcare 
professionals.   It is integral to patient care management and impacts patient outcomes. Almost 
70% of patient adverse events occur due to lack of collaboration and communication between 
providers (Fewster-Thuente & Velsor-Friedrich, 2008). Collaboration and communication are 
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 improved with the use of standardized, evidence-based guidelines developed through an 
organized process.   
Multiple frameworks have been provided intended to organize process of developing 
evidence-based guidelines. Examples include those proposed by Melynk and Fineout-Overholt 
(2011), Rosswurm and Larrabee (1999), Stetler (2001), and Johns Hopkins Hospitals and Clinics 
(Newhouse, Dearholt & Poe, 2005). The Iowa Model (Figure 1) is representative of the 
processes discussed in these models. This model is used/reprinted with permission from the 
University of Iowa Hospitals and Clinics and Marita G. Titler PhD, RN, FAAN, copyright 1998 
(Appendix B). It offers the healthcare provider a logical sequential flow to follow in an easy to 
read algorithm. In 2010 the Advanced Practice Nursing department at Orlando Health adopted 
the Iowa model as the preferred process to follow when considering the implementation of EBP 
process changes at this system. It is important to note that the Iowa model was not used during 
the development of EDSSAPP as this process was initiated in 2009 prior to the model’s selection 
by this healthcare system.  
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Figure 1: The Iowa model of evidence-based practice to promote quality care 
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 The following discussion is a comparison of the EDSSAPP process development with the 
steps of the Iowa model. This review was conducted in order to determine if the EDSSAPP 
process development correlated with EBP implementation guidelines as seen in the Iowa model. 
This evaluation demonstrated that the steps followed in EDSSAPP evolution mirrored the Iowa 
model up to the point of evaluation and dissemination of results. 
The Iowa Model process begins with the identification of a trigger or clinical problem. In 
this case Orlando Health, using the SSC materials began looking at ways to improve the early 
identification of severe sepsis and combine this with timely and appropriate treatment. 
Organizational data confirmed suspicions that severe sepsis was indeed a threat to patients in this 
hospital system just as discussed in the international literature. The next step, following this 
model, was to determine the relevance of this severe sepsis project to the healthcare 
organization’s mission and strategic plan. The significance of severe sepsis at this organization 
had previously been acknowledged in 2006 prior to the SCCM’s presentation of the SSC so the 
problem or trigger had previously been identified as pertinent and continues to be in line with the 
organization’s goal to decrease mortality. 
Next, the Iowa Model algorithm calls for the formation of a team to gather and review 
evidence related to the identified problem. A multidisciplinary team was formed to develop this 
process in the Orlando Regional Medical Center (ORMC) Emergency Department (ED). Once 
the literature was evaluated, synthesized and ranked, the team determined what if any practice 
changes were necessary. Once this foundational work had been completed, the team agreed on 
the desired outcomes and corresponding EBP guidelines and an order set was developed. This 
ED’s multidisciplinary team carefully reviewed and discussed the SSC’s initial resuscitation 
bundle (Appendix C) addressing the first six hours of care and from these developed EDSSAPP. 
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 Care was taken to ensure each component of the SSC bundle was reviewed, addressed and 
adapted as appropriate in both the treatment protocol and order set developed for implementation 
in our ED setting.  
The Iowa Model states that the team may determine if it is best to first pilot the proposed 
process changes prior to full implementation. A pilot allows for the team to evaluate the process 
and to receive feedback from the frontline healthcare providers prior to full implementation. The 
ED team determined that the EDSSAPP process being introduced followed similar existing 
processes already used in the trauma and cardiac populations; therefore a trial or pilot was not 
needed.  The next step post implementation is to carefully evaluate if this new process has 
changed practice and improved patient outcomes. As there was no pilot of EDSSAPP the next 
step for this team was to develop a formal process to continually monitor and evaluate 
EDSSAPP data and implement changes as necessary.  
The Iowa model’s last step is to recognize and address any identified challenges related 
to the changes made or EBP processes implemented. When EDSSAPP was first implemented a 
process was put into place to gather data on each of the ED patients that had a Severe Sepsis 
Alert (SSA) activated. Despite the collection of SSA patient’s data there has not been any formal 
evaluation conducted related to this EDSSAPP data. This study is an objective evaluation of 
EDSSAPP and its impact on the severe sepsis patient population in this ED. According to the 
Iowa Model it is important for key members of the team to actively, continually and closely 
monitor the process and associated data that demonstrate the healthcare team’s adherence to 
following the process and determining if any changes are necessary to sustain the evidence based 
practice changes. It is essential to communicate the ongoing data results with the entire 
healthcare team in order to encourage adherence and move forward to a sustained culture 
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 change. It is this step in the Iowa Model that this severe sepsis study will complete, an evaluation 
and dissemination of the data at different time intervals since its original implementation to 
determine the impact it has had on this patient population’s morbidity and mortality in this 
healthcare system.  
Severe Sepsis Challenges in Emergency Departments 
As established, the appropriate treatment of sepsis is time sensitive. Studies conducted by 
the SCCM and others have demonstrated the importance of early interventions with standard 
practice protocols and guidelines in order to improve outcomes for septic patients. One excellent 
example of successful implementation of the SSC program was in 2010 at the Catholic 
Healthcare West healthcare system (Rauber, 2010). This facility reported that three years after 
implementing the SSC guidelines a reduction of inpatient death rates by 33%, as well as a 
decrease on healthcare costs by $36.5 million.  Unfortunately, the Emergency Department (ED) 
is especially challenged to implement time-sensitive protocols.  
Since 1990 the number of hospital-based emergency departments in the U.S. has declined 
by 27% while the number of patient visits has increased by 30% (Hsia, Kellermann & Shen, 
2011). Between 1998 and 2008 there were more than 123 million visits to our nation’s ED’s. As 
the world’s economy continues to struggle, there are increasing numbers of uninsured and 
underinsured individuals seeking healthcare in ED’s. The Emergency Medical Treatment and 
Active Labor Act (EMTALA), a federal anti-dumping law passed in 1986 requires ED’s to do a 
medical screening exam on all patients seeking emergency medical care, regardless of their 
ability to pay. These challenging economic conditions make the nations’ ED’s a “safety net” for 
the entire healthcare system. As ED patient volumes and acuities continue to increase, so do 
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 delays in treatments and department overcrowding. It is not uncommon for ED’s to care for 
admitted patients for extended periods of time while waiting for inpatient beds to become 
available. These throughput challenges can potentially contribute to the quality of care provided 
to patients seeking care in the ED. Clark and Normile (2007) noted in a 2003 Government 
Accounting Office report that the most common cause of delayed admission to the hospital was 
holding admitted patients in the ED due to a lack of critical care bed availability. The ED is 
simply not designed or staffed to care for patients over extended periods of time, especially 
critically ill or injured patients (Chalfin et al., 2007). 
The Orlando Health Project 
In response to the call for increased awareness and action, in October 2006 the SCCM 
presented the SSC to a select gathering of clinical leaders at Orlando Health.  Following this 
introduction, corporate-wide teams were formed to develop a system-wide educational program 
based on the SSC materials. The primary educational goal was to teach clinical personnel to 
“Recognize, Respond and Rescue” septic patients at all the facilities in the Orlando Health 
system (Orlando Health Computer Assisted Instruction Program, 2007). 
Once the educational process was in place and clinical provider education underway the 
next step was to establish teams to evaluate clinical areas for potential process changes that 
would include the SSC guidelines. Pertinent to the prominent role of the ED in early detection of 
sepsis, in February 2008 the ORMC ED/Level One Trauma Center sepsis team was formed. This 
multidisciplinary group included the following ED personnel: clinical pharmacist, phlebotomist, 
staff Registered Nurse (RN), Clinical Nurse Specialist (CNS), attending physician, and resident 
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 physician. In addition, a representative from the hospital data/quality department also 
periodically participated.  
In September 2009 the finalized Emergency Department Severe Sepsis Alert and Practice 
protocol (EDSSAPP) along with an order set based on the SSC guidelines were implemented in 
the ED (Appendix D). As recommended by the SSC the multi-disciplinary group that developed 
the EDSSAPP guidelines included an algorithm to increase early recognition of severe sepsis 
patients and initiation of EGDT. In addition, components of this protocol are intended to 
expedite the patient admission process.  
Since the implementation of EDSSAPP there has been no formal evaluation of this 
process to determine the impact of this EBP-driven project on patient outcomes. For this reason a 
snap-shot audit data review was performed in 2010. Data were collected through a retrospective 
electronic medical record (EMR) audit of all Severe Sepsis Alerts called from the date of 
implementation: September 2009 to August 2010. For comparison purposes baseline data were 
also obtained from a retrospective EMR audit for the six months prior to the implementation of 
EDSSAPP. The data items collected at pre and post EDSSAPP implementation are noted in 
Table 1.  
 
Table 1: Pre and post alert audit data items  
Pre Alert Post Alert 
The shift of arrival  The shift of arrival 
Gender  Gender  
Time of  arrival to time of first antibiotic given Time of  arrival to time of first antibiotic given  
Average hospital length of stay Average hospital length of stay 
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 In order to ensure inter-rater reliability, all data were collected by the ED CNS and one 
ED staff nurse who volunteered to assist with the EDSSAPP project.  
Early EDSSAPP Findings 
As noted in the Table 2, between March and September of 2009 there were 37 patients 
admitted through the ED to a monitored unit at this facility with the diagnosis of severe sepsis or 
septic shock. For the first six months post implementation of EDSSAPP (from September 2009 
to March 2010) there were 49 patients admitted to a monitored unit with the diagnosis of severe 
sepsis or septic shock and of these there were only 19 SSA’s called. These data suggest that the 
EDSSAPP process was only being utilized approximately 38.7% of the time. 
 
Table 2: Pre and post implementation audit data  
Variables Pre Implementation Data Post Implementation Data 
Time frame and number 
totals.  
3/09 – 9/09: 37 patients 
admitted with diagnosis of 
severe sepsis/septic shock  
9/09 – 3/10: 49 patients admitted with diagnosis of severe 
sepsis/septic shock  
30 (61.2%) patients met severe sepsis/septic shock 
criteria and had NO ALERT called.  
19 (38.7%) met severe sepsis/septic shock criteria and 
HAD ALERTS called.  
Shift of arrival  7a – 7p: 73% 
7p - 7a: 27% 
7a – 7p: 55% 
7p - 7a: 45% 
Gender  27% Female 
73% Male 
32% Female 
68% Male 
Time of  arrival to time 
of first antibiotic given 
1 hour or less: 0% 
1-2 hours: 9% 
2-3 hours: 4.5% 
3-4 hours: 3.2% 
Greater than 4 hours: 83.3%   
1 hour or less: 73% 
1-2 hours: 14% 
2-3 hours: 4% 
3-4 hours: 9% 
Greater than 4 hours: 0%   
Average hospital length 
of stay 
10.5 days 7.9  days 
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 Discussion of EDSSAPP Audit Findings 
Despite the fact that Severe Sepsis Alerts were not being initiated on all patients who met 
the criteria, there was improvement in processes related to treating severely septic patients.  The 
one component that had the most significant change was the time to first antibiotic 
administration. The goal was to administer the antibiotic within one hour of the patient’s arrival 
to the ED. The audit data demonstrated the numbers went from 0% antibiotics administered 
within one hour to 73% of ED severe sepsis patients receiving their initial antibiotics within in 
one hour of arrival to the ED. In addition, the data also showed the hospital had an overall 
decrease in length of stay for this population from 10.5 to 7.9 days during this time frame. These 
audit results were presented in a poster at the annual Emergency Nurses Association’s Scientific 
Assembly in 2010 (Appendix E) and inspired the development of this study, ED staff involved in 
EDSSAPP determined it was time to have a formal evaluation of this process and decide if any 
changes are needed to improve the care of this patient population.       
Doctor of Nursing Practice (DNP) Study Purpose 
Despite worldwide educational efforts and advances in care, mortality in the sepsis 
patient population continues to remain high. While the snap shot audit data presented here 
indicates an improvement in the care provided to these patients, a more thorough assessment of 
data will assist in determining what, if any changes need to be made to the current educational 
programs or to the EDSSAPP process itself.  Monitoring and evaluating EDSSAPP process using 
the Iowa Model as an organizing construct as discussed earlier will assist in determining the 
impact of this process change on patient and organizational outcomes. It is the purpose of this 
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 thesis to conduct a retrospective analysis of data associated with the SSC campaign in the ED at 
ORMC in order to advise the organization and contribute to the profession. 
The primary purpose of this study was to assess the effect of EDSSAPP implementation 
(alert-activated versus no alert- activated) on the time to first antibiotic administration, ED and 
hospital LOS, and mortality in severe sepsis patients admitted to the hospital through the ORMC 
ED across three time cohorts: 1) base line time zero (T0): six months prior to EDSSAPP 
implementation, 2) time one (T1): the first six months following the initial EDSSAPP 
implementation, and 3) time two (T2): six months following the reinstatement of the corporate 
sepsis committee.  
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 CHAPTER TWO: LITERATURE REVIEW 
Introduction  
The foundations for the literature related to the assessment and treatment of severe sepsis 
and septic shock are derived from the 1991 collaborative work of the American College of Chest 
Physicians and the Society of Critical Care Medicine. In 1992 their work was added to a global 
initiative including efforts from the European Society of Intensive Care Medicine and the 
International Sepsis Forum to begin the “Surviving Sepsis Campaign” (Bone, et al., 1992).  
Research continues today to look for ways to diagnosis sepsis early and provide the most 
effective definitive treatment. As a result there is extensive literature available addressing severe 
sepsis and septic shock. Sepsis literature, specifically related to the unique challenges faced by 
emergency departments was also plentiful.  
Orlando Health’s sepsis initiative did as the SSC recommended, implemented educational 
and process changes to “Recognize, Respond and Rescue” this vulnerable patient population. 
Information found throughout the literature mirrors the experiences at the ORMC ED during this 
process change. Now, following the Iowa model algorithm a study was conducted to determine if 
EDSSAPP has positively impacted patient outcomes.  
The focus of this chapter is to discuss the review of literature addressing the barriers to 
and strategies for developing and implementing process change related to the care of severe 
sepsis patients in the ED, evaluate the currently available diagnostic laboratory testing for sepsis, 
and analyze post process change successes seen in the ED setting. Appendix F is the Literature 
Review Summary table.  
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 Diagnostic Tools to Determine Severe Sepsis  
 Patients presenting with symptoms of severe sepsis or septic shock must not only have 
the history of their present illness determined, but their comprehensive medical history 
accurately obtained as well. One of the valuable tools available to the clinician to assist in 
determining the diagnosis of sepsis is laboratory testing. The following three serum tests-C-
reactive protein (CRP), Lactate, and Procalcitonin (PCT) - are helpful in evaluating and 
determining if the patient is septic.     
CRP is protein that is normally found in the blood and can be measured when 
inflammation is suspected. The challenge the clinician faces is that this level is also increased in 
other conditions: surgery, traumatic injuries, burns, or any inflammatory process. Therefore, 
CRP can increase the provider’s suspicion for sepsis; however, it is not reliable as a definitive 
diagnostic test for sepsis (Lee et al., 2008).  
Lactic acid (lactate) is the level of acid in the blood stream and was first measured in 
human serum in 1843 by Scherer while describing a patient in septic shock (Jansen et al 2009). 
Elevated lactate levels indicate anaerobic metabolism, a condition seen in patients with severe 
sepsis and septic shock. The clinician must use caution, however, when using lactate as an 
indication of sepsis as elevated levels may also be seen in patients following strenuous exercise, 
in patients with liver disease, kidney disease or heart failure. In 2009 Arnold et al. looked at 
lactate levels and found that the earlier a patient can normalize the lactate level, the higher the 
probability they would survive. The authors’ conclusions were that following a patient’s lactate 
levels and making efforts at lowering the value a priority for continued treatment are an 
important component of care in the septic patient population. However, Jansen et al. (also in 
2009) conducted systematic review of the technology related to lactic acid measurements and its 
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 reliability in assisting to make a diagnosis of sepsis and found this finding to be questionable. 
While this study questioned lactate levels’ reliability in diagnosing severe sepsis, the authors did 
agree that this has a place in the assessment and treatment of septic patients and should be just 
one tool used to assist, but not replace the clinician’s assessment or clinical judgment. Vanzant 
and Schmelzer (2011) also evaluated the use of lactate levels in diagnosing and treating septic 
patients and came to a similar conclusion. These authors stated that measuring serum lactate is a 
quick and easily obtained laboratory test in the ED and therefore should be included in the 
assessment process. While high lactate levels will alert the clinician that this patient is at a 
greater risk for mortality it is not specific enough to clearly identify the potential cause of the 
patient’s condition. Shapiro et al (2005) noted that identifying sepsis in the ED is a challenge to 
clinicians as the signs and symptoms are subtle and currently there is no definitive diagnostic test 
available. Shapiro et al. did agree that high lactate levels were clearly associated with higher 
mortality in septic patients. In addition, they also found that 4.9% of patients in their study with 
sepsis who despite having normal lactate levels died. They concluded that lactate levels, while a 
valuable bio-marker in the assessment of these patients is not the reliable as a single diagnostic 
test for this patient population.    
Procalcitonin (PCT) is another serum laboratory test that may be useful for the clinician 
when evaluating potentially septic patients. This is a fairly new inflammation bio-marker that can 
be helpful in determining the presence of a bacterial infection. A 2010 a study by de Kruif et al. 
conducted in 310 bed teaching hospital compared CRP results in febrile ED patients to the PCT 
levels in those same patients. Their findings demonstrated that PCT was more specific for 
bacterial infection while the CRP was more sensitive for the presence of inflammation. Used in 
combination, PCT and CRP would be valuable additions to the laboratory diagnostic tests for 
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 patients with suspected sepsis.  They did, however, note that common use of PCT as a bio-
marker has not yet been established as a standard component of care in the ED. A study by Lee 
et al. (2008) supported the de Kruif conclusions, noting that PCT can be a valuable laboratory 
test for the clinician who suspects sepsis when it is used in conjunction with assessment findings 
and clinical judgment.  
The literature supports that while there is no single laboratory test currently available to 
reliably diagnosis sepsis, multiple tests combined with assessment findings and clinical judgment 
are the key in determining if the patient is septic.   
Barriers to Implementation of Evidence Based Guidelines  
In an effort to encourage use of the SSC guidelines, the 2008 International Guidelines for 
the Management of Severe Sepsis and Septic Shock (Dellinger et al.2008) carefully spelled out 
in detail the steps in recognizing sepsis. They evaluated the quality of the evidence used to 
support the guidelines and treatment options. These recommendations include antibiotic therapy, 
source control, intravenous fluid therapy, contemplation of vasopressors, inotropes and 
corticosteroids. Each section has a discussion and the rationale for each recommendation. The 
information in these guidelines provides the clinician with the necessary tools to understand the 
science behind the recommendations so appropriate informed treatment decisions can be made as 
expeditiously as possible.      
Although the literature supports the utilization of the SSC guidelines to standardize care, 
many authors also agree that guidelines are not intended to take the place of the clinician’s 
knowledge or experience (Dontje, 2007).  The clinician should not ignore the individual patient’s 
medical history or the clinician’s assessment findings and clinical judgment. The challenges 
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 faced in ED’s are twofold, first how to recognize sepsis early and second, how to consistently 
initiate the SSC EGDT as the standard treatment.      
 EGDT through implementation of interdisciplinary order sets or patient care bundles has 
a positive impact on patient outcomes. Despite the knowledge that the utilization of these 
bundles results in positive patient outcomes, there continues to be inconsistent implementation 
and adherence to them worldwide (Weinert & Mann, 2008). According to Weinert and Mann, 
(2008) there is a new arm of research emerging to look at these delay issues. This 
implementation science, a new way to disseminate research is also called T2 or translational 
research. It is a way for healthcare providers looking to help discover why there are delays in 
getting research to the bedside and ways to get findings adopted into practice sooner.   
Many barriers to implementation have been acknowledged. Weinert and Mann (2008) 
identified that “guideline development and implementation strategies have occasionally 
overshadowed the guidelines actual content” (pg. 463). Some additional reasons noted for the 
underutilization of guidelines were the perceived lack of consideration for the individual 
patient’s history and co-morbidities, and the possibility of excessive influence or financial stake 
by authors or third party entities as the guidelines were being developed.  
Related to ED adherence specifically, only 7% of emergency physicians from 30 
academic tertiary care facilities reported that they used any EGDT when caring for their patients 
(Carlbom and Rubenfeld 2007). These authors also concluded the results of their study were 
consistent with other initiatives such as treatment for ventilator-associated pneumonia and hand 
washing. Carlbom and Rubenfeld acknowledged that there are many challenges in getting 
knowledge gained from research and applying it at the bedside.  
23 
 The literature clearly supports that the treatment of severe sepsis and septic shock should 
be developed using the evidence based SSC EGDT guidelines. It also shows that the time it takes 
to initiate EGDT guidelines after the clinician recognizes severe sepsis or septic shock greatly 
influences the patient’s outcomes (Dellinger et al., 2008). For every hour delayed in the 
administration of antibiotics in the severe sepsis patient the risk for a poor outcome increases by 
7.6% (Zubert et al. 2010). Similarities of increased mortality secondary to the delay of time to 
treatment can also be found in the trauma population. In trauma care, the golden hour is the time 
immediately following injury, when survival is dependent on rapid assessments and appropriate 
resuscitative interventions (Advanced Trauma Life Support, 2012).   
The reluctance of healthcare providers to accept EGDT and change care delivery has 
been compared to the same resistance seen when guidelines and protocols were developed to 
care for the cardiovascular, stroke, and trauma populations (Huang et al., 2007). Some of the 
barriers identified by administrators and clinicians are directly related to concerns that practice 
changes can result in increased costs secondary to a lack of facility resources. ED overcrowding, 
the absence of multidisciplinary education specific to sepsis patients, a general lack of 
understanding of the mortality benefits of EGDT, and the absence of organizational leadership 
support account for the lack of EGDT implementation.  
The literature suggests that support for sepsis initiatives can be solicited from both 
healthcare providers and the organizational leadership by sharing with them successful 
implementation data from facilities that have already initiated established EBP protocols.  The 
positive impact on patient outcomes, the decrease in patient’s length of stays (LOS), and reduced 
costs associated with the improved patient outcomes can and should be convincing rationale for 
change. For example, it has been calculated that an ED that treats 91 severely septic or septic 
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 shock patients annually and consistently practices EGDT would realize an estimated savings of 
approximately $788,606 a year (Haung et al., 2007). In addition, facilities that are already 
centers for stroke, trauma, and cardiac patients would more than likely already have the 
necessary multidisciplinary healthcare providers, technology and protocols in place to positively 
impact the septic patient population without making extensive changes.  
Program Implementation Efforts  
 In an effort to encourage adherence, a program called MUST (Multiple Urgent Sepsis 
Therapies) was developed at the Beth Israel Deaconess Medical Center in Boston.  It included 
the rationale for each step of the protocol during its development. In addition, they creatively 
adapted their trauma patient flow sheet used for nursing documentation to be available 
specifically for septic patients (Jones, Shapiro & Roshon, 2007). As the format of this document 
was already familiar to the staff and easy to use, the authors expected adherence would be high. 
This same multidisciplinary group of clinicians also used a variety of educational techniques for 
all the different disciplines prior to the protocol’s implementation. Post implementation, the team 
monitored adherence to the protocol and communicated with the individual healthcare providers 
after each septic patient was seen in the ED. The group’s goal was to develop an expectation that 
there was accountability by all members of the team for the care they provided. Since its 
implementation, this protocol has been established as the standard of care for the ED. Despite the 
general acceptance of the new standard, this facility’s team admits that they continue to 
encounter occasional challenges with compliance and hope that their consistent case reviews will 
demonstrate that this program is being sustained. In order to sustain positive changes strategies 
must include continued reviews and open communications with providers.    
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 In a study conducted at a large university based hospital in Madrid, researchers evaluated 
their ED to determine if the physicians were using the sepsis bundle as implemented (de Miguel-
Yanes et al., 2006). They found that during the two month long study the ED census totaled 
31,238 patients. There were multiple missed septic patients and two patients who were thought to 
have sepsis but were later determined to not be septic. In response to the results of this evaluation 
the researchers concluded that the best way to improve the early recognition and treatment of 
septic patients was to create a multidisciplinary collaborative team and develop a comprehensive 
education program for the entire hospital staff. The strategy of multidisciplinary collaboration is 
seen throughout the literature as an important component for development, implementation, and 
sustaining positive changes.  
 In a comprehensive study by Nguyen et al. (2007) they describe a process of bundle 
development followed by extensive sepsis education of the ED personnel and finally 
implementation of the developed processes followed by an evaluation of the implementation 
itself. Despite their extensive and intensive efforts the researchers noted that it took two years 
post implementation to achieve a greater than 50% adherence to bundle use in the ED.   
 Several themes from the literature related to implementation of guidelines and protocols 
have been identified. Multidisciplinary collaboration, not only between physicians and nurses, 
but also different specialty areas within the facility, was a primary factor for success. This was 
closely followed by an organized and systematic approach to the literature review, protocol 
development, facility wide education and an evaluation program that included following up with 
the individual healthcare providers post case review.  
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 Post Implementation Evaluations    
 Evaluating the impact of implementing any change in practice is an important component 
of the change process. As a way to assist facilities and evaluate improvements the SSC 
developed a performance improvement program and recruited 165 hospitals worldwide to 
participate resulting in 15,022 patients being entered into their data base (Levy et al., 2010). The 
purpose of this program was to determine the extent of practice changes and determine if use of 
the SSC guidelines improved patient outcomes. Hospital participation in this program was 
completely voluntary. Facilities were asked to enter data components related to the SSC 
guidelines from the first six hours resuscitation bundle and the second 24 hour management 
bundle into the secure data base. The data demonstrated overall good levels of compliance with 
the first three measures in the six hour bundle. Those measures were obtaining serum lactate 
levels, blood cultures prior to initial antibiotic administration, and administering appropriate 
broad-spectrum antibiotic. Early recognition of sepsis by lactate measurement was done 86% of 
the time. Obtaining blood cultures prior to antibiotic administration and initiation of appropriate 
antibiotic therapy was documented 78% of the time. Interestingly, these three components are 
most consistently performed in the ED. Although the outcomes of this performance improvement 
process are not the result of formal scientific research these results demonstrated a decrease in 
patient mortality when providers used the SSC guidelines. The authors did note, however, that 
some of the decrease in mortality might also be attributed to patients being less critically ill when 
enrolled as first thought.  
 Mikkelsen et al. (2010) looked specifically at the challenges one emergency department 
faced during implementation and if EGDT was being consistently utilized for patients 
experiencing severe sepsis and septic shock. The facility identified that utilization of the EGDT 
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 guidelines had, over the two year evaluation time frame, 2005 to 2007, decreased from 61% to 
40%. Their results demonstrated that mortality rates for patients who had EGDT started but not 
completed was at 36% while in patients who had EGDT initiated and completed mortality rate 
was decreased to 30%. In addition, the authors noted an interesting discrepancy related to the use 
of EGDT among the 33 ED physicians at this facility. When the treating ED physician was 
female, EGDT was implemented 48.5% of the time compared to 62.4% of the time for their male 
counterparts. The data also demonstrated that the younger physicians, with the least years of 
experience in practice utilized EGDT guidelines more frequently than their older and more 
experienced colleagues. The authors acknowledged their study’s interesting age and gender 
findings related to implementation of EGDT and noted the need to investigate this further.  In 
addition, they suggested that EGDT protocol adherence might be improved if a “consultation 
service” was created and became involved early in the patients care. The EDSSAPP audit 
findings discussed earlier showed that SSA’s were only being activated 38.7% of the time; these 
results are in line with facilities as found in the literature. Further research is needed to help 
identify barriers to implementation of EGDT.    
Looking back at the ORMC EDSSAPP process in light of information gained from this 
comprehensive literature review, there is one component that stands out as most likely a 
contributing factor to the perceived low numbers of SSA’s being activated- the gathering and 
sharing of real time data with the healthcare team members.   
Early Goal Directed Therapy/Safe and Cost Effective Care   
 Today’s healthcare environment requires facilities to provide safe and quality care while 
continuously striving to maintain cost effectiveness. Shorr et al., (2007, pg 1257) cited that the 
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 “costs of sepsis are staggering and total tens of billions of dollars annually” and implementation 
of evidenced-based sepsis protocols can result in substantial savings in both lives and costs of 
care. Studies by Jones, Troyer and Kline (2011) and Talmor, Greenberg, Howell, Lisbon, 
Novack and Shapiro (2008) looked at the cost effectiveness of implementing EGDT. In the 
Talmor et al study (2008), the authors noted that once EGDT was initiated there was an increase 
in both time and resources needed to care for septic patients. They also cited an increased LOS in 
the intensive care unit (ICU) and associated care costs. The Jones et al. study (2011) had similar 
results, concluding implementation of EGDT had indeed increased associated care costs. In both 
studies, while the direct costs calculated for caring for severe sepsis and septic shock increased 
after the implementation of EGDT, there were also corresponding increases in quality-adjusted 
life years (QALYs) of the patients who survived. A QALY is defined as an estimate of how 
many years of life that a reasonable person might gain secondary to medical treatment. There are 
several factors considered when measuring the quality of life as related to the individual’s health. 
These contributing factors include pain, and general ability to perform activities of daily living. 
While the authors all agreed the indirect life year’s savings made up for the rise in direct care 
costs for sepsis patients it is important to note that these were single center studies.      
 Lagu et al. (2011) used data collected by the Premier Healthcare Informatics in Charlotte 
North Carolina, from 309 hospitals that treated 166,931 septic patients from 2004 to 2006. Their 
goal was to determine if there was any association between the amount of money a hospital spent 
on the care of septic patients and improved survival rates for these patients. The authors carefully 
selected facilities and conducted complex statistical analyses to evaluate the outcomes.  The 
study results demonstrated care of the septic patient varies widely across the US and there was 
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 no obvious association between increased hospital spending on costs of direct care for the septic 
patient and improved patient survival rates. 
 Powell, Khare, Courtney and Feinglass (2010) also found results similar to Lagu et al. 
(2011) related to the variety of care provided to sepsis patients in hospitals across the US. Data 
for this study included 87,166 adult septic patients seen and treated in 551 US hospitals. The 
results demonstrated ED’s experiencing higher volumes of septic patients were more likely to 
have better-quality care for this vulnerable population. Clark and Normile (2007) identified that 
holding admitted patients in the ED awaiting in house bed availability can contribute to increased 
patient mortality. They also noted that mortality was increased on weekend shifts versus 
weekday shifts. Despite the increased mortality for patients being held for admission Clark and 
Normile’s data did show that septic patients who were seen and received initial treatment in the 
ED did receive their antibiotics, on average, one hour sooner than patients directly admitted to an 
inpatient bed.  
The amount of literature available related to sepsis will continue to grow as the healthcare 
community searches for ways to identify sepsis early and researchers look for the most effective 
definitive treatment. In addition, it will not only be important for clinicians to stay abreast of the 
latest related evidence but to find ways to implement the necessary changes to improve patient 
outcomes and decrease mortality.    
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 CHAPTER THREE: METHODS 
Severe sepsis is a significant threat to patients worldwide. While the previously reviewed 
EDSSAPP audit snap-shot data demonstrated that this process had improved care for severely 
septic patients in this organization’s ED, a more thorough evaluation of the process and its 
associated outcomes was needed. Implementation of EBP requires practice change(s), as was 
noted in the steps of the Iowa model. In addition, an analysis of the process changes and 
associated data with a continued evaluation of the quality of care being delivered is necessary to 
ensure improved patient outcomes. Another important step in this process is the dissemination of 
results, communicating to the healthcare community is an important component as this 
contributes to new knowledge and assists in demonstrating that translating research into practice 
can improve care at the bedside.   
The main goal of this study was to evaluate the impact of EDSSAPP, pre and post 
implementation, on severe sepsis patients admitted via the ORMC ED. Specific components of 
the process were selected for review based on their importance in contributing to positive patient 
outcomes. Following the Iowa model process for implementation of evidence-based practice 
recommendations, monitoring this process change and associated outcomes along with 
disseminating the results is one way to contribute to sustaining the positive changes.  
Research Aim 
The primary aim of this study was to assess the outcomes of EDSSAPP on severe sepsis 
patients admitted via the ORMC ED across three time cohorts on: 
• Alert activated versus no alert activated  
• Time to first antibiotic administration 
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 • Total ED and hospital LOS 
• Mortality  
Study Design 
A retrospective review of data from the electronic medical record (EMR) was conducted 
to gather the required data for the following cohorts:  
1. Base line/time zero (T0):  six months prior to the implementation of EDSSAPP; the 
purpose of this data was for comparison with the other two time cohorts.   
2. Time one (T1):  the first six months following initial EDSSAPP implementation, to 
determine the immediate impact of EDSSAPP.   
3. Time two (T2):  six months following reinstatement of the corporate sepsis committee; 
these data were used for further comparisons to determine the impact of EDSSAPP.  
Research Questions 
All the data gathered for this study were analyzed to answer the following research 
questions. 
a. In ED patients with severe sepsis what was the effect of EDSSAPP on time to first 
antibiotic administration at three time cohorts, T0, T1, and T2?       
a. In ED patients with a severe sepsis alert activated, what was the effect of EDSSAPP 
on time to first antibiotic administration between time cohorts T1 and T2? 
b. In ED patients without a severe sepsis alert activated what was the effect of 
EDSSAPP on time to first antibiotic administration between time cohorts T0, T1, and 
T2? 
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 c. In ED patients with and without a severe sepsis alert activated, what was the effect of 
EDSSAPP on time to first antibiotic administration within groups at time cohort T1? 
d. In ED patients with and without a severe sepsis alert activated, what was the effect of 
EDSSAPP on time to first antibiotic administration within groups at time cohort T2? 
2.1  In ED patients with severe sepsis, what was the effect of EDSSAPP on ED LOS across 
three time cohorts T0, T1 and T2?  
a. In ED patients with a severe sepsis alert activated, what was the effect of EDSSAPP 
on ED LOS between time cohortsT1 and T2?  
b. In ED patients without a severe sepsis alert activated, what was the effect of 
EDSSAPP on ED LOS between time cohorts T0, T1 and T2? 
c. In ED patients with and without a severe sepsis alert activated, what was the effect of 
EDSSAPP on ED LOS within groups at time cohort T1?  
d. In ED patients with and without a severe sepsis alert activated, what was the effect of 
EDSSAPP on ED LOS within groups at time cohort T2?  
2.2   In ED patients with severe sepsis, what was the effect of EDSSAPP on hospital LOS 
across three time cohorts T0, T1 and T2?  
a. In ED patients with a severe sepsis alert activated, what was the effect of EDSSAPP 
on hospital LOS between time cohortsT1 and T2?  
b. In ED patients without a severe sepsis alert activated, what was the effect of 
EDSSAPP on hospital LOS between time cohorts T0, T1 and T2? 
c. In ED patients with and without a severe sepsis alert activated, what was the effect of 
EDSSAPP on hospital LOS within groups at time cohort T1?  
33 
 d. In ED patients with and without a severe sepsis alert activated, what was the effect of 
EDSSAPP on hospital LOS within groups at time cohort T2?  
3.  In ED severe sepsis patients, what was the effect of EDSSAPP on mortality between time 
cohorts T0, T1 and T2?  
4.  In ED severe sepsis patients, what was the effect of EDSSAPP with reactivation of the 
corporate sepsis committee on the number of severe sepsis alerts activated between time 
cohorts T1 compared to T2? 
a. In ED severe sepsis patients, what was the effect of EDSSAPP with reactivation of 
the corporate sepsis committee on the number of severe sepsis patients with a severe 
sepsis alert activated between time cohorts T1 compared to T2?  
b. In ED severe sepsis patients, what was the effect of EDSSAPP with reactivation of 
the corporate sepsis committee on the number of severe sepsis patients without a 
severe sepsis alert activated between time cohorts T1 compared to T2?  
Subject Sampling  
The cohort data were obtained between 2009 and 2013 and a description of each cohort 
can be seen in Table 3. Subjects included in T0 were a convenience sample of 22 patients 
admitted to the hospital from the ORMC ED with any of the initial ICD 9 codes listed in Table 4 
that did not have a SSA activated. Subjects without a SSA activated in T1(n = 26) and T2 (n = 
21) were also a convenience sample consisting of all patients admitted to the hospital from the 
ORMC ED with any of the initial ICD 9 codes listed in Table 3. All SSA activated patients from 
T1 (n = 19) and T2 (n = 113) were obtained from the existing EDSSAPP log. The lists of 
subjects with no SSA activated that were admitted for all three time cohorts from the ORMC ED 
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 were obtained following approval from the Orlando Health Nursing Research Council, the 
ORMC and UCF IRB with waiver of consent, and application process to the Corporate Office of 
Safety and Transformation, Clinical Analysis and Outcomes (CAO) at Orlando Health as 
required by the organization’s policy.   
 
Table 3: EDSSAPP patient cohorts  
Baseline: Pre-EDSSAPP 
Implementation 
T0 
Cohort 1: Post-EDSSAPP 
Implementation 
T1 
Cohort 2: Post-Reinstatement of 
Corporate Sepsis Committee 
T2 
4/1/09 to 9/28/09  9/29/09 to  3/31/10 8/14/12 to 2/14/13 
Patients with Severe Sepsis 
(n=22) 
Severe sepsis/septic shock 
patients meeting inclusion 
criteria for the six months prior 
to implementation of 
EDSSAPP.  
Patients with Severe Sepsis Alert 
Activated  (n=19) 
Severe sepsis/septic shock patients for 
the first six months post 
implementation of EDSSAPP meeting 
inclusion criteria that had a severe 
sepsis alert paged.   
Patients with Severe Sepsis Alert 
Activated  (n=113) 
Severe sepsis/septic shock patients for 
six months post reinstatement of 
corporate Sepsis committee activity 
meeting inclusion criteria that had a 
severe sepsis alert paged.   
 Patients without Severe Sepsis Alert 
Activated  (n=26) 
Severe sepsis/septic shock patients for 
the first six months post 
implementation of EDSSAPP who met 
inclusion criteria and did NOT have a 
severe sepsis alert paged. 
Patients without Severe  
Sepsis Alert Activated  (n=21) 
Severe sepsis/septic shock patients for 
six months post reinstatement of 
corporate Sepsis committee activity 
meeting inclusion criteria and did NOT 
have a severe sepsis alert paged.   
 
Inclusion criteria consist of all ORMC ED patients who were:  
• 18 years or older 
• Admitted to the hospital through this ED during the assigned time cohorts 
• Diagnosed with any of the ICD-9 codes listed in Table 4 with or without a SSA activated 
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 Exclusion Criteria consists of all ORMC ED patients who were:  
• Younger than 18 years 
• Admitted to the hospital through the ORMC ED without an initial ICD-9 code as listed in 
Table 4 
•  Expired in the ED, or were not admitted to this facility  
• All patients that were transferred to a nursing home, skilled nursing facility, or hospice 
outside the Orlando Health system from the ED  
Setting 
The Orlando Regional Medical Center (ORMC) ED is a 58 bed, state-certified, level one 
trauma center. The average daily census is 200 patients with 30% to 37% of these patients being 
admitted to the hospital. ORMC is a Joint Commission-accredited facility, and the ED is staffed 
by board-certified emergency physicians and emergency medicine residents. The ED’s nursing 
staff has a wide range of experience from one year to thirty years with approximately 20% of the 
nursing staff holding the national certification- Certified Emergency Nurse (CEN). In addition, 
the ED is staffed by state certified paramedics, licensed clinical social workers, licensed 
respiratory therapists, radiology technicians, certified phlebotomists and advanced clinical 
technicians. Standardized evidence-based guidelines are currently implemented for the trauma, 
cardiac and stroke patient populations.   
Protection of Human Subjects 
As this was a retrospective EMR review, the only direct risk to subjects selected for this 
study is the possible breach of confidentiality. In addition, there are no direct or indirect benefits 
to these subjects. This study was presented to the Nursing Research Council and following their 
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 approval was submitted to the Institutional Review Boards at both the University of Central 
Florida and Orlando Health, approval letters are provided in Appendices G, H, I. Consent was 
obtained from Orlando Health to use the EDSSAPP process for this study (Appendix J). 
Confidentiality 
The data protection plan for this study includes ensuring that all data were de-identified, 
entered into the secured electronic spread sheets and kept on a password protected computer and 
encrypted flash drive locked in the Clinical Nurse Specialist’s office.   
Data Collection  
Initial electronic lists of ED patients hospitalized for the three cohorts were obtained from 
the hospital’s CAO Department. Once these lists were screened for inclusion criteria, the specific 
approved variables were collected through a comprehensive retrospective EMR review by the 
study team. The study data obtained included the approved descriptive, independent, and 
dependent variables for all the groups in each of the three time cohorts and can be seen in Table 
4 along with the statistical test planned to analyze the data. A sample of the spreadsheet that was 
used for data entry can be seen in Appendix K.  
 
Table 4: Descriptive variables and data analysis plan 
Descriptive Variables 
Variable Level  of 
Measurement 
Coding Statistical Test 
Day of the week Nominal 1= Monday 
2= Tuesday 
3= Wednesday 
4= Thursday 
5= Friday 
Frequencies, percent  
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 Descriptive Variables 
Variable Level  of 
Measurement 
Coding Statistical Test 
6= Saturday 
7= Sunday 
Time of arrival 
 
Scale Clocked military time Will be used to calculate 
time to initial antibiotic 
Mode of arrival 
  
Nominal 1= Private car 
2= EMS 
Frequencies, percent 
Gender 
 
Nominal 0= Male  
1= Female 
Frequencies, percent 
Age  
 
Scale Age in years.  Frequencies, percent;  
Mean, Mode, Median, 
Standard Deviation 
Race 
 
Nominal 1= Caucasian 
2= Hispanic 
3= African American 
4= Asian 
5= Other 
Frequencies, percent 
ICD-9 codes Nominal 1. 38.0 Strep sepsis  
2. 38.11 MRSA Sepsis 
3. 38.12 Methicillin-resistant 
Staphylococcus aureus (MRSA) 
septicemia 
4.38.19 Staphylococci 
septicemia NEC 
5. 38.40 Gram-neg septicemia 
(NOS) 
6. 38.42 Ecoli sepsis 
7. 38.43 Pseudomonas 
septicemia  
8. 38.44 Serratia septicemia 
9. 38.49 Gram-neg septicemia 
NEC  
10. 38.9 Septicemia NOS 
11. 670.04 Major puerp 
infection NOS-p/p 
12. 728.86 Necrotizing Fasciitis 
13. 785.52 Septic Shock 
14. 995.91 Sepsis 
15. 995.92 Severe Sepsis 
16. 999.31 Infection due to 
central venous catheter 
Frequencies, percent 
Presenting complaint 
 
Nominal Open category Frequencies, percent 
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 Descriptive Variables 
Variable Level  of 
Measurement 
Coding Statistical Test 
Initial ED  lactate level Scale Number 
mEq/L 
Frequencies, percent;  
Mean, Mode, Median, 
Standard Deviation 
Initial ED lactate serum source Nominal 1= Venous 
2= Arterial 
Frequencies, percent 
Initial ED White Blood Cell 
Count 
Scale Number (cells per mcL) Frequencies, percent;  
Mean, Mode, Median, 
Percent, Standard 
Deviation 
Time from order to First 
Antibiotic Administration 
Scale Calculated from the time of 
EDMD order to the time of 
EDRN initiation of 
administration.  
Frequencies, percent;  
Mean, Mode, Median, 
Percent, Standard 
Deviation 
Time of discharge from ED Scale Military Time Used to calculate ED 
LOS (minutes?) 
ED LOS  Scale  Calculated from the time of 
arrival to the ED to the time 
departed from the ED to in-
patient bed.  
Frequencies, percent;  
Mean, Mode, Median, 
Percent, Standard 
Deviation 
Hospital LOS Scale  Time of arrival to ED to time of 
discharge from the hospital or 
death.  
Frequencies, percent;  
Mean, Mode, Median, 
Percent, Standard 
Deviation 
Mortality Nominal 1=Discharged 
2=Expired 
Frequencies, percent 
Number of Severe Sepsis 
patients admitted to the hospital 
from the ED during the noted 
time frames  
Scale Number of severe sepsis patients 
admitted from the ED.  
Frequencies, percent;  
Mean, Mode, Median, 
Percent, Standard 
Deviation 
 
The ICD-9 codes were used as a part of the inclusion criteria with 16 initial codes related 
to sepsis approved for this study can be seen in Table 5. At the beginning of data gathering the PI 
and Co-PI elected to gather only one initial admission and principal ICD-9 code on each of the 
EMR’s as these patients had multiple ICD-9 codes, some had as many as 20 per patient record.  
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 Table 5: Initial ICD-9 codes 
ICD-9 Code Definition 
38.0 Strep sepsis  
38.11 MRSA Sepsis 
38.12 Methicillin-resistant Staphylococcus aureus (MRSA) septicemia 
38.19 Staphylococci septicemia NEC 
38.40 Gram-neg septicemia (NOS) 
38.42 Ecoli sepsis 
38.43 Pseudomonas septicemia  
38.44 Serratia septicemia 
38.49 Gram-neg septicemia NEC  
38.9 Septicemia NOS 
670.04 Major puerp infection NOS-p/p 
728.86 Necrotizing Fasciitis 
785.52 Septic Shock 
995.91 Sepsis 
995.92 Severe Sepsis 
999.31 Infection due to central venous catheter 
 
The most complex variables to measure were the patient’s initial/presenting complaints. 
The Principal Investigator (PI) and statistician collaborated to categorize this variable in order to 
have a meaningful way to calculate the data. The patients initial/presenting complaints were 
grouped by systems and a summary of these groupings and their associated percentage per cohort 
are listed in Table 9 in Chapter 4.   
Inter-Rater Reliability 
Inter rater reliability was established by the PI prior to any data gathering by the research 
team. As a part of the CNS’s practice, EMR’s are regularly reviewed for audits and process 
improvement projects; this activity supports CNS as the PI’s expertise in EMR review. The CNS 
chose five severe sepsis charts and gathered the required data. Next, the team of co-investigator 
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 and sub-investigators were given the same five charts independently to abstract the required data 
points. The inter-rater reliability data sheets were reviewed and scored for accuracy against the 
CNS completed data sheet. A 100% matching was obtained and accurate inter-rater reliability 
achieved. None of the investigators failed to meet the required standard and no remediation or 
reevaluation was needed.       
Statistics and Data Analysis 
 Data were entered into the approved SPSS (v 21) spread sheets followed by a thorough 
review to ensure accuracy by the PI and statistician. Descriptive and inferential statistics were 
run as appropriate to the research questions as seen in Table 6. The data related to the ED and 
hospital LOS were not normally distributed, therefore non-parametric statistics were run.   
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 Table 6: Data analysis plan by research questions 
Research Questions Variable Level of 
Measurement 
Coding Statistical Test 
RQ 1. In ED patients with severe sepsis what was the effect of EDSSAPP on time to first antibiotic administration at three time cohorts, T0, T1, and T2?      
a. In ED patients with a SSA activated, what 
was the effect of EDSSAPP on time to first 
antibiotic administration between time cohorts 
T1 and T2? 
IV: EDSSAPP  
 
 
DV: Total antibiotic time (from 
initial antibiotic order to time of 
antibiotic administration) 
Nominal 
 
 
Nominal 
0=No 
1=Yes 
 
1= <60 minutes 
2= > 60 minutes 
Chi Square 
b. In ED patients without a SSA activated, 
what was the effect of EDSSAPP on time to 
first antibiotic administration between time 
cohorts T0, T1, and T2? 
IV: EDSSAPP  
 
 
DV: Total antibiotic time (from 
initial antibiotic order to time of 
antibiotic administration) 
Nominal 
 
 
Nominal 
0=No 
1=Yes 
 
1= <60 minutes 
2= > 60 minutes 
Chi Square 
c. In ED patients with and without a SSA 
activated what was the effect of EDSSAPP on 
time to first antibiotic administration within 
time cohort T1? 
IV: EDSSAPP  
 
 
DV: Total antibiotic time (from 
initial antibiotic order to time of 
antibiotic administration) 
Nominal 
 
 
Nominal 
0=No 
1=Yes 
 
1= <60 minutes 
2= > 60 minutes 
Chi Square 
d. In ED patients with and without a SSA 
activated what was the effect of EDSSAPP on 
time to first antibiotic administration within 
time cohort T2? 
IV: EDSSAPP  
 
 
DV: Total antibiotic time (from 
Nominal 
 
 
Nominal 
0=No 
1=Yes 
 
1= < 60 minutes 
Chi Square 
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 Research Questions Variable Level of 
Measurement 
Coding Statistical Test 
initial antibiotic order to time of 
antibiotic administration) 
2= > 60 minutes 
RQ 2.1. In ED patients with severe sepsis what was the effect of EDSSAPP on ED LOS across three time cohorts T0, T1 and T2?  
a. In ED patients with a SSA activated what 
was the effect of EDSSAPP on ED LOS 
between time cohorts T1 and T2? 
IV:  EDSSAPP  
 
 
DV: ED LOS 
Nominal 
 
 
Ratio 
0=No 
1=Yes 
 
Number of minutes 
Mann-Whitney U 
b. In ED patients without a SSA activated 
what was the effect of EDSSAPP on ED LOS 
between time cohorts T0, T1 and T2? 
IV:  EDSSAPP  
 
DV: ED LOS 
Nominal 
 
Ratio 
0=No 
1=Yes 
 
Number of minutes 
Kruskal Wallis test 
c. In ED patients with and without a SSA 
activated, what was the effect of EDSSAPP on 
ED LOS within time cohorts at T1? 
IV:  EDSSAPP   
 
 
DV: ED LOS 
Nominal 
 
 
Ratio 
 
0=No 
1=Yes 
 
Number of minutes 
Mann-Whitney U 
d. In ED patients with and without a SSA 
activated, what was the effect of EDSSAPP on 
ED LOS within time cohorts at T2? 
IV:  EDSSAPP   
 
 
DV: ED LOS 
Nominal 
 
 
Ratio 
0=No 
1=Yes 
 
Number of minutes 
Mann-Whitney U 
RQ 2.2. In ED patients with severe sepsis what was the effect of EDSSAPP on hospital LOS across three time cohorts T0, T1 and T2? 
a. In ED patients with a SSA activated what 
was the effect of EDSSAPP on hospital LOS 
between time cohorts T1 and T2? 
IV:  EDSSAPP  
 
 
Nominal 
 
 
0=No 
1=Yes 
 
Mann-Whitney U 
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 Research Questions Variable Level of 
Measurement 
Coding Statistical Test 
DV: hospital LOS Ratio Number of days 
b. In ED patients without a SSA activated 
what was the effect of EDSSAPP on hospital 
LOS between time cohorts T0, T1 and T2? 
IV:  EDSSAPP  
 
DV: hospital LOS 
Nominal 
 
Ratio 
0=No 
1=Yes 
 
Number of days 
Kruskal Wallis test 
 
 
c. In ED patients with and without a SSA 
activated, what was the effect of EDSSAPP on 
hospital LOS within time cohorts at T1? 
IV:  EDSSAPP   
 
 
DV: hospital LOS 
Nominal 
 
 
Ratio 
0=No 
1=Yes 
 
Number of days 
Mann-Whitney U 
d. In ED patients with and without a SSA 
activated, what was the effect of EDSSAPP on 
hospital LOS within time cohorts at T2? 
IV:  EDSSAPP   
 
 
DV: hospital LOS  
Nominal 
 
 
Ratio 
0=No 
1=Yes 
 
Number of days 
Mann-Whitney U 
RQ 3. In ED severe sepsis patients, what was the effect of EDSSAPP on mortality between time cohorts T0, T1 and T2? 
RQ 3. In ED severe sepsis patients, what was 
the effect of EDSSAPP on mortality between 
time cohorts T0, T1 and T2? 
IV: EDSSAPP 
 
 
DV: Mortality 
Nominal 
 
 
Nominal 
0= No 
1= Yes 
 
0=No 
1= Yes  
Chi Square 
RQ 4. In ED severe sepsis patients, what was the effect of EDSSAPP with reactivation of the corporate sepsis committee on the number of severe sepsis 
patients with and without a severe sepsis alert activated between time cohorts T1 compared to T2? 
RQ 4. In ED severe sepsis patients, what was 
the effect of EDSSAPP with reactivation of the 
corporate sepsis committee on the number of 
IV:  EDSSAPP with reactivation of 
corporate  sepsis committee 
 
Nominal 
 
 
0= No 
1= Yes 
 
Chi Square  
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 Research Questions Variable Level of 
Measurement 
Coding Statistical Test 
severe sepsis patients with and without a 
severe sepsis alert activated between time 
cohorts T1 compared to T2? 
DV: Number of SSAs and SSNAs   
Nominal 
 
0= No 
1=Yes 
a. In ED severe sepsis patients, what was the 
effect of EDSSAPP with reactivation of the 
corporate sepsis committee on the number of 
severe sepsis patients with a severe sepsis alert 
activated between time cohorts T1 compared 
to T2?  
IV:  EDSSAPP with reactivation of 
corporate  sepsis committee 
 
DV: Number of SSAs 
Nominal 
 
 
 
Nominal 
0= No 
1= Yes 
 
 
0= No 
1=Yes 
Chi Square  
 
b. In ED severe sepsis patients, what was the 
effect of EDSSAPP with reactivation of the 
corporate sepsis committee on the number of 
severe sepsis patients without a severe sepsis 
alert activated between time cohorts T1 
compared to T2? 
IV:  EDSSAPP with reactivation of 
corporate  sepsis committee 
 
DV: Number of S0SAs 
Nominal 
 
 
 
Nominal 
0= No 
1= Yes 
 
 
0= No 
1=Yes 
Chi Square  
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 CHAPTER FOUR: RESULTS 
 In this chapter the results of the data analyses are presented followed by the findings as 
related to each of the study questions. Data were examined for missing values, outliers and 
normality as appropriate. Descriptive statistics, frequencies, Chi Square, Mann- Whitney U, and 
Kruskal Wallis tests were used for this study. Data were analyzed using the Statistical Package 
for the Social Sciences (SPSS) version 21.   
 Raw data were obtained following the approved process and the data were received in an 
Excel spread sheet via secure hospital email. A total of 2,330 patients were included in the initial 
raw data requested. Once the data were screened using the inclusion and exclusion criteria, a 
total of 201 patients were included. Table 7 is a summary of the total number of patients that 
populated each of the study cohorts. A table of the entire EDSSAPP demographic data is shown 
in Appendix L.    
 
Table 7: Sample size per time cohort  
Cohort No Alert Activated Alert Activated Total 
TIME 0 22 0 22 
TIME 1  26 19 45 
TIME 2 21 113 134 
Total 69 132 201 
Time 0 = Pre EDSSAPP, Time 1 = First 6 months post EDSSAPP implementation, Time 2 = EDSSAPP following 
the reactivation of corporate sepsis committee. 
 
Sample Characteristics  
The demographic data were for each of the cohorts individually and for the total study 
population as a whole. Demographic data and baseline characteristics for this study are 
summarized in Table 8. 
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 Table 8: EDSSAPP demographic data 
Size 
Time Cohorts 
All Time 
Cohorts 
Time 0 Time 1 Time 2 
No Alert Alert No Alert Alert No Alert 
(n = 22) (n = 19) (n = 26) (n = 113) (n = 21) 
201 (100%) 22 
(10.94%) 
19  
(9.45%) 
26 
(12.93%) 
113 
(56.21%) 
21 
(10.44%) 
C
ha
ra
ct
er
ist
ic
 
Age Mean  
(sd) 
 
 
Median 
(range) 
 
62.42 (18.47) 
 
 
64.0  
(19-102) 
 
59.86 
(18.31) 
 
63.5 
(23-90) 
 
62.37 
(20.78) 
 
68.0  
(23-93) 
 
53.62 
(21.53) 
 
52.0  
(19-88) 
 
64.95 
(16.66) 
 
67.0 
(19-95) 
 
62.43 
(19.82) 
 
62.0  
(29-102) 
Gender Mean 
(%) 
    Male 
    Female 
 
 
103 (51.2) 
98 (48.8) 
 
 
9 (40.9) 
13 (59.1) 
 
 
14 (73.7) 
5 (26.3) 
 
 
17 (65.4) 
9 (34.6) 
 
 
57 (50.4) 
56 (49.6) 
 
 
6 (28.6) 
15 (71.4) 
Race Mean 
(%) 
    Caucasian 
    Black 
    Hispanic 
    Asian 
 
 
116 (57.7) 
60 (29.9) 
21 (10.4) 
4  (  2.0) 
 
 
14 (63.6) 
4 (18.2) 
3 (13.6) 
1 (4.5) 
 
 
13 (68.4) 
6 (31.6) 
0 (0.0) 
0 (0.0) 
 
 
14 (53.8) 
8 (30.8) 
4 (15.4) 
0 (0.0) 
 
 
65 (57.5) 
36 (31.9) 
10 (8.8) 
2 (1.8) 
 
10 (47.6) 
6 (28.6) 
4 (19.0) 
1 (4.8) 
Alert Status 
Mean 
(%) 
    Alert  
    No Alert 
 
 
 
132 (65.7) 
69 (34.4) 
 
 
 
0 (0.0) 
22 (100) 
 
 
 
19 (100) 
0 (0.0) 
 
 
 
0 (0.0) 
26 (100) 
 
 
 
113 (100) 
0 (0.0) 
 
 
 
0 (0.0) 
21 (100) 
 
Of the 201 patients, the mean age for the total sample was 62.42 years (range 19-102 
years, SD 18.47 years). Most were white (57.7%) with an even gender distribution of male 
(51.2%) and female (48.8%). The majority had a severe sepsis alert activated (65.7%).   
47 
 Presenting/Chief Complaint 
The initial presenting/chief complaints varied widely as the EMR documentation of the 
complaints were based on what the patient or family stated to the ED staff on arrival. To 
organize these complaints in a systematic way for statistical analysis the study’s PI and 
statistician collaborated to group the presenting or chief complaints by placing them into medical 
system categories. A non-parametric test (Kruskal Wallis) was conducted comparing the ED 
chief complaints in each category across the three time cohorts. The only chief complaint 
category that was statistically significant was skin/wounds with a p value of .001, despite the 
total number of patients in this category being small (n= 9). The list of the system categories and 
associated complaints, with numbers, percentages and p values are listed in Table 9. 
 
Table 9: Initial/presenting complaint summary  
System Examples of Conditions 
Total T0 T1 T2 p values 
n (%) n (%) n (%) n (%) 
Metabolic 
 
Hypoglycemia 
Fever/chills 
Electrolyte imbalance 
Sepsis  
Hyperglycemia 
Flu like symptoms  
Septic shock 
56  (27.9) 4 (18.2) 10 (22.2) 42(31.3) .43 
Neurologic 
 
Altered mental status 
Un-responsive 
Seizures  
Near syncope 
Syncope 
51 (25.4) 8 (36.4) 12 (26.6) 31(23.1) .40 
Respiratory 
 
Pneumonia 
Shortness of breath 
Respiratory distress 
Difficulty breathing 
31 (15.4) 5 (22.7) 7(15.5) 19(14.2) .35 
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 System Examples of Conditions 
Total T0 T1 T2 p values 
n (%) n (%) n (%) n (%) 
Pleural  
Effusion  
Hemoptysis 
Gastro-
intestinal 
 
Abdominal pain  
Displaced peg tube 
Abdominal abscess   
Nausea and vomiting  
Diarrhea 
Rectal bleeding  
Liver failure 
Small bowel obstruction 
Vomiting and diarrhea 
Partial small bowel 
obstruction 
Rectal pain 
18 (9.0) 1 (4.5) 3 (6.6) 14(10.4) .15 
Cardiac 
 
Hypo-tension 
Chest pain 
Supra- ventricular tachycardia 
STEMI alert 
12 (6.0) 3 (13.6) 2 (4.4) 7 (5.2) .50 
Skin-Wounds 
 
Abscess 
Multiple wounds 
Gangrene 
Decubitus ulcer  
Infected dialysis catheter 
wound 
9 (4.5) 0 (0.0) 6 (13.3) 3 (2.2) .001 
Genital-
urinary 
 
Urinary tract infection  
Need dialysis  
Hematuria 
Urinary retention  
Dysuria 
3 (1.5) 0 (0.0) 0 (0.0) 3 (2.2) .89 
Other 
 
Problem with central venous 
line 
Pain 
Weakness 
21 (10.4) 1 (4.5) 5 (11.1) 15(11.2) .35 
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 System Examples of Conditions 
Total T0 T1 T2 p values 
n (%) n (%) n (%) n (%) 
Displaced tube 
Pulled muscle  
General illness 
Failure to thrive 
 
Research Questions 
Research Question 1: Antibiotic Administration 
In ED patients with severe sepsis what was the effect of EDSSAPP on time to first antibiotic 
administration at three time cohorts T0, T1 and T2?  
Antibiotic administration times were placed into two groups: those < 60 minutes and 
those > 60 minutes for statistical analysis based on the EDSSAPP antibiotic administration time 
requirement. A Chi-Square test was conducted comparing antibiotic time (< 60 minutes versus > 
60 minutes) in patients with severe sepsis (with and without a severe sepsis alert activated) in 
time cohorts T0, T1, and T2. No statistically significant differences in time of antibiotic 
administration was found between T0, T1, and T2 (p = .38), results are listed in Table 10.   
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 Table 10: ED antibiotic administration times by time cohorts and groups 
Characteristics Time Cohorts X2 
p value 
 
All Patients 
T0 
n = 22 
T1  
n = 45 
T2  
n = 134 
 
Antibiotic Time 
< 60 minutes 
n (%) n (%) n (%)  
    Yes 18 (81.8) 32 (71.1) 108 (80.6) .38 
    No 4 (18.2) 13 (28.9) 26 (19.4)  
Groups: 
Severe Sepsis Alert  
No Alert 
n = 22 
Alert 
n = 19           
No Alert 
n = 26 
Alert 
n = 113            
No Alert 
n = 21 
 
p value 
Antibiotic Time 
< 60 minutes 
n (%) n (%) n (%) n (%) n (%)  
    Yes 18 (81.8) - 19 (73.1) - 18 (85.7) .74 
     No 4 (18.2) - 7 (26.9) - 3 (14.3)  
     Yes - 13 (68.4) - 90 (79.6) - .52 
     No - 6 (31.6) - 23 (20.4) -  
     Yes - 13(68.4) 19 (73.1) - - .35 
     No - 6 (31.6) 7 (26.9) - -  
     Yes - - - 90 (79.6)  18 (85.7) .51 
     No - - - 23 (20.4) 3 (14.3)  
 
Research Question 2.1: ED Length of Stay 
In ED patients with severe sepsis, what was the effect of EDSSAPP on ED LOS across three time 
cohorts T0, T1 and T2?   
A Kruskal Wallis test was conducted comparing the ED LOS of patients with severe 
sepsis at the three different time cohorts. Although the ED LOS was shorter in T1, there was no 
significant difference in ED LOS across the three time cohorts (p = .14).  
a. In ED patients with a severe sepsis alert activated, what was the effect of EDSSAPP on 
ED LOS between time cohorts T1 and T2?  
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 A Mann-Whitney U test was conducted comparing the mean ED LOS in patients with a 
severe sepsis alert activated in T1 versus T2. There was a statistically significant lower ED LOS 
in patients with a severe sepsis alert activated in cohort T1 (365.32 minutes) compared to T2 
(422.88 minutes) resulting in a  p value of .05. 
b. In ED patients without a severe sepsis alert activated, what was the effect of EDSSAPP 
on ED LOS between time cohorts T0, T1 and T2?  
A Kruskal Wallis test was conducted comparing the ED LOS of patients without a severe 
sepsis alert activated at the three different time cohorts. Although the ED LOS was shorter for 
patients without a severe sepsis alert activated in T1, there was no overall significant difference 
in ED LOS across the three time cohorts (p = .44).  
c. In ED patients with and without a severe sepsis alert activated, what was the effect of 
EDSSAPP on ED LOS at time cohort T1?  
A Mann-Whitney U test was conducted comparing the ED LOS in patients with and 
without a severe sepsis alert activated in T1. Although there was a shorter ED LOS for patients 
that had a SSA activated there was no significant difference found between the groups (p=.32).   
d. In ED patients with and without a severe sepsis alert activated, what was the effect of 
EDSSAPP on ED LOS at time cohort T2?  
A Mann-Whitney U test was conducted comparing the mean ED LOS in patients with 
and without severe sepsis alert in T2. Although there was a shorter ED LOS for patients that had 
a SSA activated there was no significant difference was found between groups (p=.37). 
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 Research Question 2.2: Hospital Length of Stay 
In ED patients with severe sepsis, what was the effect of EDSSAPP on hospital LOS across three 
time cohorts T0, T1 and T2?   
A series of non-parametric tests (Mann - Whitney U and Kruskal Wallis) were conducted 
comparing the hospital LOS in patients with and without a SSA activated in time cohorts T0, T1, 
and T2. The following changes occurred but were not statistically significant: overall the hospital 
LOS was shorter in T1 (mean rank 94.1) compared to T0 (mean rank 97.8) and T2 (mean rank 
103.84) with a p value of .60.      
a. In ED patients with a severe sepsis alert activated, what was the effect of EDSSAPP 
on hospital LOS between time cohorts T1 and T2?  
A Mann-Whitney U test was conducted comparing mean hospital LOS in patients with a 
severe sepsis alert activated in T1 versus T2. There was no significant difference in hospital LOS 
in patients with a severe sepsis alert activated in cohorts T1 compared to T2 (p = .51).  
b. In ED patients without a severe sepsis alert activated, what was the effect of 
EDSSAPP on hospital LOS between time cohorts T0, T1 and T2?  
A Kruskal Wallis test was conducted comparing the hospital LOS of patients without a 
severe sepsis alert activated at the three different time cohorts. Although the hospital LOS was 
shorter in T1, there was no overall significant difference in hospital LOS across the three time 
cohorts (p = .94). 
c. In ED patients with and without a severe sepsis alert activated, what was the effect of 
EDSSAPP on hospital LOS at time cohort T1?  
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 A Mann-Whitney U test was conducted comparing hospital LOS in patients with and 
without a severe sepsis alert activated in T1. There was no significant difference in hospital LOS 
(p = .75).  
d. In ED patients with and without a severe sepsis alert activated, what was the effect of 
EDSSAPP on hospital LOS at time cohort T2?  
A Mann-Whitney U test was conducted comparing hospital LOS in patients with and 
without a severe sepsis alert activated in T2. There was no significant difference in hospital LOS 
(p = .54).  
 
Table 11: ED and hospital length of stay by time cohorts and groups 
 
Characteristics 
Time Cohorts  
p value T0 T1  T2  
  ED Length of Stay a 
 (range in minutes) 
442.18 
(163-881) 
394.10 
(67-807) 
533.00 
(54-1772) 
 
.14 
  ED Length of Stay b 
(range in minutes) 
 
- 
394.10 
(67-807) 
533.00 
(54-1772) 
 
.05 
  Hospital Length of Stay a 
 (range in days) 
11.95 
(1-60) 
9.22 
(1-43) 
9.52 
(1-91) 
 
.60 
  Hospital Length of Stay b  
(range in days) 
 
- 
9.22 
(1-43) 
9.52 
(1-91) 
 
.33 
Sepsis Alert Groups Alert No Alert Alert No Alert Alert No Alert  
   ED Length of Stay a  
(range in minutes) 
 
- 
442.18 
(163-881) 
 
- 
422.88 
(67-807) 
 
- 
578.19 
(173-1442) 
.44 
   Hospital Length of Stay a  
(range in days) 
 
- 
11.95 
(1-60) 
 
- 
9.00 
(1-43) 
 
- 
8.57 
(1-21) 
 
.94 
   ED Length of Stay b  
(range in minutes) 
 
- 
 
- 
365.32 
(127-793) 
 
- 
487.81 
(54-1772) 
 
- 
 
.05 
  Hospital Length of Stay b  
(range in days) 
 
- 
 
- 
9.00 
(1-43) 
 
- 
10.48 
(1-91) 
 
- 
 
.51 
   ED Length of Stay b  
(range in minutes) 
 
- 
 
- 
365.32 
(127-793) 
422.88 
(67-807) 
 
- 
 
- 
 
.32 
   Hospital Length of Stay b  
(range in days) 
 
- 
 
- 
9.00 
(1-43) 
9.00 
(1-43) 
 
- 
 
- 
 
.75 
   ED Length of Stay b 
(range in minutes) 
 
- 
 
- 
 
- 
 
- 
487.81 
(54-1772) 
578.19 
(173-1442) 
 
.37 
   Hospital Length of Stay b  
(range in days) 
 
- 
 
- 
 
- 
 
- 
10.48 
(1-91) 
8.57 
(1-21) 
 
.54 
aKruskall Wallis; bMann-Whitney U 
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 Research Question 3: Mortality   
In ED severe sepsis patients, what was the effect of EDSSAPP on mortality between time cohorts 
T0, T1 and T2?  
A Chi Square test was conducted comparing mortality (Yes versus No) in severe sepsis 
patients (with and without a severe sepsis alert activated) between time cohorts T1 and T2, in 
comparison to T0. A statistically significant decrease in mortality (p = .04) was found in T2, T0 
(n=5, 22%), T1 (n=15, 33%) T2 (n=22, 16%). (Table 12). 
Research Question 4: Activation of   Severe Sepsis Alert. 
a. In ED severe sepsis patients, what was the effect of EDSSAPP with reactivation of the 
corporate sepsis committee on the number of severe sepsis patients with a severe sepsis alert 
activated between time cohorts T1 compared to T2?  
b. In ED severe sepsis patients, what was the effect of EDSSAPP with reactivation of the 
corporate sepsis committee on the number of severe sepsis patients without a severe sepsis 
alert activated between time cohorts T1 compared to T2?  
A Chi Square test was conducted comparing the number of severe sepsis patients with 
and without a severe sepsis alert activated (Yes versus No) between time cohorts T1 and T2. A 
statistically significant increase in the number of severe sepsis alerts activated was found 
between T1 (n=19) and T2 (n=113) resulting in a p value of .001). Although no statistically 
significant differences were found in number of severe sepsis patients that did not have a SSA 
activated between T1 (n=26) and T2 (n=21) with a p value of .06 this should be considered a 
clinical significance with more severe sepsis patients were recognized, alerted and treated.  
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 Table 12: ED severe sepsis alerts activated and mortality by time cohorts  
Characteristics Time Cohorts 
p value  
All Patients 
T0 
n = 22 
T1 
n = 45 
T2 
n = 134 
Sepsis Alert Activated n (%) n (%) n (%)  
    Yes - 19 (42.2) 113 (84.3) .001 
    No - 26 (57.8) 21 (15.6)  
Mortality     
    Yes 5 (22.72) 15 (33.33) 22 (16.42) .04 
    No 17 (77.27) 30 (66.67) 112 (83.6)  
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 CHAPTER FIVE: DISCUSSION 
This study evaluated the impact of EDSSAPP implementation on antibiotic 
administration times, length of stay (ED and Hospital), and mortality over two time cohorts (T1, 
T2) as compared to pre-implementation (T0). In addition, this study evaluated the impact of the 
corporate sepsis committee activity on the number of severe sepsis alerts activated versus not 
activated were compared during time cohorts T1 and T2.   
Study findings provide preliminary support for implementation of EDSSAPP with the 
additional corporate sepsis committee activity on improving outcomes of ED patients with severe 
sepsis. Additional research is needed to evaluate the impact of other external factors that may 
influence these outcomes, such as patient characteristics, competing patient care priorities and 
the overall ED personnel’s attitudes, perception and knowledge of the EDSSAPP process and 
goals.   
Utilization of evidence-based guidelines to address severe sepsis in the ED is an ongoing 
challenge. Barriers to implementation of and adherence to evidence-based guidelines or 
protocols include physician concerns related to the perceived lack of consideration for 
individualization of patient treatment and the potential influence of outside third parties, such as 
pharmaceutical companies, on research outcomes. The reluctance to accept standardized sepsis 
guidelines are similar to the challenges experienced when other standardized guidelines for 
diseases, such as acute coronary syndrome, stroke, and trauma, were implemented (Huang et al., 
2007). In a 2013 systematic literature review of adherence to guidelines and protocols in the pre-
hospital and emergency care settings Ebben et. al. (2013) noted that adherence to either national 
or international guidelines ranged from 7.8% to 95%. No one single reason was identified for 
this issue, rather it was recommended that in order to ensure improvements in quality patient care 
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 via the use of evidence-based guidelines and protocols strategies must be developed to increase 
healthcare providers’ adherence. As with previous guideline acceptance, more time to gather and 
review data may be needed to demonstrate positive patient outcomes from guideline utilization 
in order to have a universal acceptance of standardized sepsis guidelines in the ED. In addition, 
the local EMS agencies have instituted their own Sepsis Alert process using the SSC criteria; 
increased collaboration with our pre-hospital partners related to their sepsis alert process is a 
good first step to improve coordination of care across the continuum. 
Activation of Severe Sepsis Alert  
The most significant finding of this study was the increased number ED patients who had 
severe sepsis alerts activated in time cohort T2. The number of severe sepsis alerts activated in 
T2 (n=113) compared to T1 (n=19) was significantly increased and was most likely the result of 
influence upon ED personnel by the re-activation of the corporate severe sepsis committee.  
Literature world-wide has consistently noted that despite the evidence showing improved patient 
outcomes following the use of the SSC patient care bundles there continues to be inconsistent 
utilization (Weinert & Mann, 2008). The re-activation of the corporate sepsis committee in T2 
(8/2012 – 2/2013) resulted in focused directed activities including physician to physician 
communications and CNS clinical rounding in an effort to increase the ED personnel’s 
awareness of severe sepsis and adherence to EDSSAPP. Though not statistically significant, the 
number of ED severe sepsis patients that did not have an alert activated decreased from T1 
(n=26) to T2 (n=21). In a study by Nguyen et.al. (2007) they noted that despite their intensive 
and extensive efforts to educate personnel and increase utilization of their severe sepsis bundles 
it took over two years to finally reach greater than 50% compliance with their sepsis bundle use. 
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 This study was conducted over 18 months and as seen in the literature it takes time to implement 
process changes and consistent efforts to sustain the changes. The CNS role is uniquely designed 
to both lead evidence-based change and support collaboration with multidisciplinary personnel to 
sustain the changes.        
Mortality   
Another important finding was that mortality significantly decreased at T2 (16.4%) 
compared to T0 (22.7%) and T1 (33%). The re-activation of the corporate sepsis committee and 
active involvement of the CNS with rounding and on-going continuous efforts to increase staff 
awareness of EDSSAPP may have influenced reducing mortality compared to the EDSSAPP 
intervention alone. However, despite the reduction of mortality in T2 compared to T0 and T1, the 
number of patients who received antibiotics in less than 60 minutes did not increase across the 
three time cohorts. T0 had 82% receive antibiotics within 60 minutes while T1 had 71% and T2 
had 81%. This is a curious finding as the literature has shown that delays in antibiotic 
administration can contribute to increased mortality for severe sepsis patients (Zubert et al. 
2010).  It is possible that the EDSSAPP order set components were being implemented on all ED 
patients with severe sepsis, even when there was no alert being activated on the patient. While 
individual order set components initiations were not collected for this study, this could be 
contributing to the lower mortality rates. Other potential contributing factors to consider are 
possible decreased ED patient volumes, allowing the staff more time to care for each patient, 
decreased patient acuities, and increased in-patient bed availability resulting in the ED not 
holding patients for extended times.      
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 Hospital and ED LOS 
The hospital length of stay was significantly increased by almost 1.5 days between those 
patients with a severe sepsis alert activated in T1 (9.00 days) compared to time T2 (10.48 days).  
Also, there was no significant decrease in the ED LOS across time cohorts and between groups 
of patients who had a severe sepsis alert activated versus no alert activated. However, there was a 
1 hour and 28 minute lower in ED LOS in patients who had a severe sepsis alert activated in T1 
compared to T0. Also, there was a 1 hour and 52 minutes lower in ED LOS between patients 
who had a severe sepsis alert activated compared to those who had no alert activated in T2. One 
potential contributing factor to either the increased or decreased ED LOS when a SSA is called is 
the role of the hospital administrative supervisors (AS). The AS’s receive the notification when a 
SSA is called. This allows them to evaluate all the patients currently waiting to be assigned in-
patient beds. Using the information related to each patient’s acuity level could potentially move 
the SSA patient to the top of the list thereby decreasing their ED LOS. The AS process and it’s 
contribution to ED LOS was not evaluated as a part of this study.       
There are many unknown external factors that may have contributed to the increased 
hospital LOS in T2 that were not evaluated for this study  such as, patient comorbidities, hospital 
acquired complications (falls, pressure ulcers, catheter associated urinary tract infections 
[CAUTI], central line associated blood stream infections [CLABSI], discharge placement, 
etc.).The Institute of Medicine brought attention to the need to improve patient care and safety 
by reducing/preventing medical errors in their 2000 To Err is Human report. This report 
estimates that the total costs of these errors include longer hospital stays and related medical 
treatment, loss of life, productivity and disability is potentially greater than $29 billion every 
year in the US (IOM Report, 2000).    
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 ED’s are challenged to rapidly identify severe sepsis patients as this illness creates a wide 
variety of symptoms which can mimic many other serious medical conditions. This makes the 
assessment process a complex endeavor while searching for a definitive diagnosis and initiating 
the appropriate treatment an ongoing challenge (Raghavan & Marik, 2006). The complexity of 
presenting signs and symptoms masking the actual cause of the patient’s acute illness influences 
the patient’s initial acuity prioritization (triage level) and ED bed assignment. In addition, it is 
important to consider that frequently multiple patients present at the same time for evaluation 
and treatment in the ED resulting in potential delays in ED bed availability. For the purposes of 
this study these influencing factors were not evaluated but should be considered for future 
studies.  ED throughput or ED bed availability as well as in-patient bed availability also impacts 
the ED LOS and is a challenge worldwide. These throughput challenges can potentially 
contribute to the quality of care provided to patients seeking care in the ED. As Clark and 
Normile (2007) noted in a 2003 Government Accounting Office report the most common cause 
of delayed admission to the hospital was holding admitted patients in the ED due to a lack of 
critical care bed availability. The ED is simply not designed or staffed to care for patients over 
extended periods of time, especially critically ill or injured patients (Chalfin et al., 2007). 
Antibiotic Administration   
Overall, the number of ED patients with severe sepsis who received antibiotics within 60 
minutes or less as required by EDSSAPP did not improve across the three time cohorts, T0 
(81.8%), T1 (71.7%) and T2 (80.6%). There are several unknown external factors that may have 
contributed to the variability in the number of patients who received antibiotics as required by 
EDSSAPP, (competing patient acuity priorities, increased ED patient volumes, difficulty 
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 obtaining venous access, etc.) that may have influenced the nurses’ availability to administer the 
ordered antibiotics. Administering antibiotics within one hour in any busy emergency department 
is a formidable task as reflected in the literature and not successful until organized and 
systematic approaches are taken with consistent data review and follow up with providers 
(Zubert 2010).   
In a study by Powell, Khare, Courtney and Feinglass (2007) they found that sepsis 
patients admitted through an ED  having received an initial assessment and initiation of treatment 
had a lower mortality rate (17.1%) than sepsis patients who were made a direct admit to an in-
patient bed not coming through the ED (19.7%). While this study provided mixed results and the 
ED continues to work towards more consistent adherence to EDSSAPP the care provided in the 
ED is a valuable contribution to improving outcomes for this patient population.  
Implications 
ED throughput is a challenge nationwide as noted in the literature. The longer patients are 
held in the ED awaiting placement to in-patient beds, the greater the chance for poor outcomes 
(Clark & Normile 2007). These poor patient outcomes are most likely secondary to the lack of 
ED staff and expertise to provide care for patients over prolonged periods of time; this is 
especially true of critically-ill or injured patients (Chalfin et al., 2007). The ORMC ED admits 
approximately 30% to 37% of its daily volume of patients. When the hospital has a high in-
patient census, this can increase the time for notification that an in-patient bed is ready to receive 
an ED patient for admission. It may have been beneficial to review hospital census data at T0, T1 
and T2 to determine its impact on admission delays. Increased ED LOS therefore could have a 
negative influence on the time to treatment initiation for one or more ED patients. Any decrease 
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 in ED LOS could increase the ED’s ability to potentially initiate treatment for other ED patients. 
The average daily census in this ED is 200 patients, which is approximately eight patients treated 
every hour.  For every hour that a patient is held in the ED awaiting a ready in-patient bed, the 
ED could have initiated treatment for up to eight patients waiting for evaluation and treatment. In 
addition to the potential delay in care holding admitted patients can cause, there is also a possible 
loss of revenue for the hospital as patients frustrated with long waits leave the ED without being 
seen and treated. 
One surprising result from this study was found in the evaluation of patient 
chief/presenting complaints. The number of patients with skin/wounds diagnosis increased from 
baseline (p < .001). Patients were assigned to this category based upon the following complaints: 
abscess, multiple wounds, gangrene, decubitus ulcers(s), infected dialysis catheters and general 
wounds. As seen in Chapter 4, this category had zero in T0, six in T1 and three in T2. The 
meaningfulness of this finding given the small number of patients assigned to this category is 
unclear and needs further investigation in future studies. However, from a clinical perspective 
communicating this finding to ED staff may increase awareness for possible sepsis in all patients 
presenting with existing wounds and other complaints as listed in this category.     
Study Limitations 
Several limitations should be considered when reviewing the EDSSAPP data results. The 
first being, that this study was conducted at one facility. While these results will be used to 
improve care provided in this ED they are not generalizable to other facilities. Following the 
analysis it was apparent that there were some data that were not included in EDSSAPP that 
might have enhanced this study. These include patient comorbidities, hospital acquired 
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 infections/injuries and patient acuity levels. In addition, the individual components of the 
EDSSAPP order set and the ED and hospital census/capacity, during the different time cohorts 
were not evaluated. This study did not examine the hospital critical shortage of in-patient bed 
availability, also known “code green, yellow, red, and purple.” This is in part due to the 
hospital’s lack of a process to accurately track the in-patient bed availability status. This process 
was not taken into consideration for the purposes of this study, which is a limitation, but may be 
an explanation for the increased hospital LOS for both alerts and non-alerts in Time 2. While 
some findings were clinically significant, the sample size was small and not able to detect a 
statistical difference given the effect size of the outcome variable which may have been different 
with an increased sample size.     
Recommendations for Practice 
The results of this study will be used to help guide the ED CNS practice and be used 
while EDSSAPP is reviewed and revised. Continued participation on the current corporate sepsis 
committee will be an important part of the multidisciplinary collaboration needed to increase 
awareness of and adherence to using the evidenced- based severe sepsis order set by the 
attending physicians and residents. The committee is currently working on a program to track the 
order set usage. This is a necessary first step toward the development of policies that require and 
enforce individual provider accountability. On-going annual and periodic education will 
coordinated with both corporate and unit based educators.    
The CNS will also lead the refinement of the existing program to closely monitor the 
SSA data and communicate these results in as close to real time as possible to the providers 
involved in the care of the alerted patient.  Select ED staff nurses have been provided special 
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 EMR access and training in order to assist in gathering data on each SSA and placing this 
information into electronic spread sheet for calculations and results review. Increased 
communication of these results to ED team members will escalate their awareness for 
sepsis/severe sepsis and EDSSAPP, see ED Process Information Updates document Appendix 
M. Improved collaborative efforts with the interdisciplinary team are needed to refocus 
everyone’s efforts to improve early recognition followed by appropriate treatment interventions 
and documentation is essential. In addition, a more formal team response to SSA’s similar to that 
of Stroke or Trauma Alerts should be considered. Communication of the monthly audit results 
could be posted for providers to review. This could assist in not only maintaining the awareness 
of sepsis/severe sepsis but the potential need for improvement on crucial components of care for 
this patient population. Lastly, the development of a formal process to follow up with individual 
providers as close to real time as possible that includes accountability for care provided and 
related documentation would also contribute to awareness and adherence. This accountability for 
care provided following evidence-based guidelines and protocols is seen in other patient 
populations (cardiac, stroke and trauma) and is being scrutinized by both third party payers and 
regulatory agencies.      
Recommendations for Future Research 
 As early recognition of sepsis is very important, it would be important to look at the time 
of arrival to the time that sepsis was suspected and interventions were initiated.  Does early 
recognition of sepsis help to prevent patients from becoming severely septic and decrease 
mortality? Can readmissions for sepsis/severe sepsis from local skilled nursing facilities (SNF) 
be reduced by the implementation of a collaborative education effort between the hospital and 
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 SNF’s? In addition, the local EMS agencies have instituted their own Sepsis Alert process using 
the SSC criteria, collaborative research with our pre-hospital partners related to their sepsis alert 
process could improve coordination of care across the continuum.  
Conclusions 
The results of this study are consistent with what is seen in the literature with no new 
findings. In order to promote acceptance and utilization of guidelines, they need to be developed 
collaboratively with an interdisciplinary team, and once implemented, employed as intended to 
improve patient outcomes. Healthcare leaders should not assume that just because a protocol 
exists it will be used as intended. Protocols and guidelines must also be frequently reviewed with 
the most current literature and be revised as new evidence is uncovered. Protocols and guidelines 
are not intended to not replace the clinical judgment of the healthcare provider but rather to 
enhance the care provided (Dontje, 2007). Healthcare professionals need to be receptive to 
changing their practice, to using the most current evidence based guidelines even when this 
challenges their traditional ways of practicing (Huang et al., 2007). Moving forward with an 
organized, systematic and interdisciplinary approach has the best chance of succeeding in 
changing practice and improving outcomes. 
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 APPENDIX A: SUMMARY OF 2008 SURVIVING SEPSIS CAMPAIGN  
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 Summary of the 2008  
Guidelines for the Management of Severe Sepsis and Septic Shock 
SSC Guideline  Recommendations 
1. Initial Resuscitation (first 6 hours) 
Resuscitation to begin STAT in patients with 
hypotension (SBP < 90), a change in Level of 
Consciousness or Glasgow Coma Score, or 
serum Lactate levels of 4 or greater. 
Do NOT wait to begin care until the patient reaches in-
house bed.  
Goals are to return patient to a hemodynamic stable 
status.   
2. Diagnosis: obtain 2 or more blood cultures and 
cultures from other sites as clinically indicated.  
Preform diagnostic imaging as indicated by 
patient’s assessment/condition.   
If possible obtain all cultures prior to administration of 
antibiotics. However DO NOT delay administration of 
antibiotics if obtaining cultures is difficult or delayed.  
3. Antibiotic Therapy to begin within one hour of 
recognizing severe sepsis/septic shock.  
Use broad spectrum therapy chosen based on the 
suspected cause. May consider multiple or combination 
medications based on co-morbidities and or patient 
responses. STOP antibiotic therapy if cause found not to 
be bacterial or known to be susceptible to current 
medication.  
4. Infectious source identification and control 
within 6 hours of arrival.  
Remove all medical devices suspected or shown to be the 
cause or contributing to the cause of infection.  
5. Fluid Therapy using crystalloids or colloids.   Rapid and large volumes may be necessary to stabilize 
hemodynamic status.  
6. Vasopressors: should NOT be administered as 
an initial treatment for a hypotensive state.   
If the patient does not positively respond to the 
administration of IV fluid then consider using 
norepinephrine or dopamine before any other pressors.   
7. Inotropic Therapy to be considered cautiously 
in patients with known cardiac dysfunction.    
Suggested medication for this patient population: 
dobutamine.  
8. Steroids are to be considered in patients with 
hypotension not responsive to fluid therapy or 
vasopressors.   
Steroidal therapy should only be used as long as 
absolutely necessary and patients must be weaned off 
this medication.  
9. Blood Products: transfuse RBC’s when Hgb is 
between 7-9 g/dL; administer platelets only 
after carefully evaluating the patient’s levels 
using SSC guideline ranges.    
Important to NOT use erythropoietin in an attempt to 
treat anemia in septic patients. Frequently monitor 
laboratory results and adjust care as indicated.  
 
10. Mechanical ventilation may be necessary so 
close and continual evaluation of both airway 
and ventilatory efforts are important.   
Interventions depend on patients’ condition and 
responses to treatment, PEEP may be required in these 
patients.  
11. Sedation should be used especially in 
mechanically ventilated patients.  
Follow critical care sedation protocols, avoid paralytics 
and closely monitor patient.   
12. Glucose control using frequent and accurate 
glucose measuring and intravenous insulin.  
Caution with POCT as individual clinician technique can 
influence quality of results.  
13. Renal replacement may be necessary/helpful in 
treating severe sepsis/septic shock.  
Continuous veno- venous hemofiltration can be helpful 
in unstable septic/septic shock patients.  
14. Bicarbonate therapy not recommended for 
treating severe sepsis/septic shock.  
Improve acidotic state in these patients via infusion of 
fluids and correction of cellular acidosis.  
15. Deep Vein prophylaxis using either low 
molecular weight heparin or a mechanical 
prophylactic device.   
May consider using a combination of therapies 
depending the patients risk for DVT.  
16. Stress Ulcer prophylaxis using H2 blockers or 
proton pump inhibitors.  
Benefits of long term prevention of GI bleeding 
important to consider along with prevention of VAP. 
17. Consideration for limitation of medical support 
based on realistic expected patient outcomes.  
Living Will and HealthCare Surrogate designation 
should be completed prior to serious illness.  
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 APPENDIX B: PERMISSION FOR USE OF THE IOWA MODEL FIGURE 
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 APPENDIX C: SURVIVING SEPSIS CAMPAIGN INITIAL RESUSCITATION 
BUNDLE 
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 2008 Six Hour Surviving Sepsis Campaign  
Resuscitation Bundle Summary 
 
This six hour resuscitation bundle is a combination of evidence-based clinical goals that must be 
completed within 6 hours of identifying severe sepsis or septic shock.  
 
1. Measure serum lactate. 
 
2. Obtain blood cultures prior to antibiotic administration (if possible). 
 
3. Administer broad-spectrum antibiotic within 3 hours of arrival to ED or within 1 hour of 
non-ED admission. 
 
4. Treat hypotension and/or elevated lactate with intravenous fluids (initial minimum of 20 
mL/kg of crystalloid).  
 
5. Administer vasopressors for hypotension not responding to initial fluid resuscitation to 
maintain mean arterial pressure (MAP) >65 mmHg. 
 
6. Administer vasopressors for hypotension not responding to initial fluid resuscitation to 
maintain mean arterial pressure (MAP) >65 mm Hg.   
 
7. Maintain central venous pressure (CVP) of >8 mm Hg. 
 
8. Achieve and maintain central venous oxygen saturation (ScvO2) >70% or mixed venous 
oxygen saturation (SvO2) >65%.  
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 APPENDIX D: EMERGENCY DEPARTMENT SEVERE SEPSIS ALERT AND 
PRACTICE PROTOCOL  
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 Orlando Regional Medical Center 
Emergency Department  
SEVERE SEPSIS ALERT GUIDELINES 
PLEASE NOTE: Nothing replaces professional CLINICAL JUDGEMENT when 
evaluating patients. If SEVERE SEPSIS IS SUSPECTED and the patient is not in an ED 
treatment bed yet INITIATE TREATMENT and notify the charge nurse STAT. 
  
Pre-Hospital/ Emergency Medical Services Process 
• When recieving an EMS radio report complete the Severe Sepsis screening section on the 
EMS report form. If positive notify the Charge nurse STAT.  
 
• Patients presenting via EMS with Suspected Severe Sepsis will be seen immediately by 
the ED staff. If assigned to an ED treatment area the appropriate RN will follow the ED 
Severe Sepsis guidelines. If no ED treatment bed is immediaetly available the ED 
paramedic will notify the ED charge nurse STAT and follow the ED Severe Sepsis 
guidelines.    
 
Emergency Department Process  
   
• Patient arrives in ED: Assessment and Severe Sepsis screening are completed and triage 
category is assigned (suspected severe sepsis patients are triage category 1 or 2). All 
appropriate documentation in Sunrise will be completed.  
• If the patient is not already in or assigned to a treatment bed notify the charge nurse 
STAT for bed assignment. The EDMD will be notified immediately that a suspected 
severe sepsis patient is in the department. Remember, the severe sepsis patient is a 
priority and treatment should begin immediately. Antibiotics should be given within one 
hour of being ordered. When available an ED phlebotomist will respond to assist with 
drawing blood and obtaining blood cultures.  
• The EDMD will evaluate the patient promptly and if severe sepsis is suspected initiate a 
SEVERE SEPSIS ALERT and appropriate Severe Sepsis Order Set.   
• When central line placement is initiated, every effort will be made to strictly adhere to 
hospital policies, including all necessary preparations and time out procedures. 
• After initial resuscitation has been initiated consider obtaining other cultures as necessary 
ie: sputum or from existing wounds.    
 
Patient Care Coordinator (PCC) process: 
 
• All of the PCC’s pagers will be activated when the “22” process for SEVERE SEPSIS 
ALERT is initiated. 
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 • The PCC’s office will call the ED “C” desk to acknowledge the SEVERE SEPSIS 
ALERT and get all necessary information from the ED regarding the patient’s condition 
and type of bed needed for admission.     
Respiratory Therapy process: 
 
• Once the SEVERE SEPSIS ALERT page is received the ED respiratory therapist will 
respond to the ED bed where the patient is being treated to obtain, if ordered, STAT 
ABG’s and perform POCT arterial lactate, if no ABG’s are ordered the RT will run a 
STAT POCT venous lactate. RT will do an ETCO2 evaluation and assist with any 
necessary respiratory support the patient may require.   
      
Radiology process: 
 
• Upon notification of a SEVERE SEPSIS ALERT the ED radiology technologist will 
respond to the ED bed where the patient is being treated to perform STAT any diagnostic 
radiology testing as required.   
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 Orlando Regional Medical Center 
EMERGENCY DEPARTMENT “SEVERE SEPSIS ALERT” PAGER LIST 
 
1. ED Respiratory Therapsist  
2. Patient Care Coordinator   
3. ED staff nurse professional pager  
4. ED Clinical Nurse Specialist  
5. ED radiology  
6. ED PharmD    
7. ED phelbotomist  
ED Secretary notifications: 
1. Senior ED Resident on duty 
2. Hospital Pharmacy 
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 Authors/Year Discipline Methods Sample/Setting Findings 
 
Arnold, R., 
Shapiro, N., Jones, 
A., Schorr, C., 
Pope, J., Casner, 
E., Parillo, J., 
Dellinger, R., 
Trzeciak, S. 
 
2008 
 
 
Medicine  
 
Using a standard 
data collection 
document 
analyzed 
consecutive ED 
patients diagnosed 
with severe sepsis 
between 2004-
2007.  
 
Patients 17 or 
older meeting 
consensus 
definitions for 
severe sepsis from 
a research 
collaborative of 3 
urban hospitals. 
 
 
A total of 166 
subjects met 
criteria. Overall 
mortality was 
23%. Mortality of 
the non-clearance 
lactate group was 
60% and 19% in 
the lactate 
clearance group. 
An important 
contributing factor 
to survival is early 
lactate clearance. 
   
 
Carlborn, D., 
Rubenfeld, G.  
 
2007 
 
Medicine 
 
National 
Telephone Survey 
with both 
quantitative and 
qualitative analysis  
 
24 Emergency 
Medicine directors 
and 40 ED nursing 
managers from 25 
of the US most 
densely populated 
areas.  
 
2 of the busiest 
teaching and 2 of 
the busiest non-
teaching hospitals 
EDs.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Both the medical 
directors and 
nursing managers 
identified multiple 
barriers to 
implementing 
components of the 
SSC resuscitation 
bundles. One 
factor seen as 
critical is the 
nursing shortage. 
Also noted was 
challenged in 
recognition of 
sepsis. Only 7% of 
EDMDs 
acknowledged 
using EGDT.    
 
Study authors 
concluded there is 
an increased need 
for collaboration 
between critical 
care medicine and 
emergency 
medicine 
physicians. The 
ED is not the best 
place for extended 
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 care for critical 
patients. 
 
Clark, K., Brush, 
L. 2007  
 
Nursing 
 
 
 
Data were 
collected between 
2001-2003 
retrospectively 
from an ED 
computer tracking 
program, and the 
corresponding in-
hospital program. 
An exploratory 
analysis of 
secondary data 
was conducted.   
 
ED patients 
admitted to the 
ICU. (1,536) 
 
Large inner city, 
level one trauma 
center and tertiary 
care hospital.  
 
The greater the 
time to first 
medication 
administration in 
the ED the longer 
the patients’ 
hospital stay. 
Recognition of the 
patient’s acuity 
and 
implementation of 
intervention’s 
impacted both 
those who walked 
into the ED and 
those who arrived 
via ambulance. ED 
throughput and 
multidisciplinary 
collaboration are 
important 
contributing 
factors.    
 
de Kruif, M., 
Limper M., 
Gerritsen, H., 
Speck, A., 
Brandjes, D., ten 
Cate, H., Bossuyt, 
M., Reitsma, P., 
van Gorp, E. 
 
2010  
 
Medicine 
 
Observational 
study using 
multiple logistic 
regression analysis 
was performed to 
determine the 
diagnostic value of 
Procalcitonin 
(PCT) in 
diagnosing sepsis.  
 
 
Patients 18 to 85 
years old who 
presented to the 
ED with fever.  
 
310 bed teaching 
hospital.  
 
211 patients met 
criteria, 73 had 
positive blood 
cultures, 104 had 
infection likely via 
imaging and 34 
had no infection 
identified.  
PCT can add value 
as a biomarker for 
sepsis when used 
in conjunction 
with c-reactive 
protein and 
clinician judgment. 
 
Dellinger, P., 
Levy, M., Carlet, 
J., Bion, J., Parker, 
M., Jaeschke, R., 
Reinhart, K., 
 
Medicine 
 
Using the Grades 
of 
Recommendation 
Assessment 
Development 
 
N/A  
 
 
International 
experts agree and 
evidence supports 
the guidelines. 
Rational is 
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 Authors/Year Discipline Methods Sample/Setting Findings 
Angus, D., Brun-
Buisson, C., Beale, 
R., Calandra, T., 
Dhainaut, J., 
Gerlach, H., 
Harvey,M., 
Marini, J., 
Marshall, J., 
Ranieri, M., 
Ramsay, G., 
Sevransky, J., 
Thompson, T., 
Townsend, S., 
Vender, J., 
Zimmerman, J., 
Vincent J. 
2008  
Evaluation 
(GRADE) tool the 
SSC 2008 
International 
guidelines for the 
management of 
severe sepsis and 
septic shock were 
systematically 
reviewed.     
provided for each 
recommendation.   
 
De-Miguel-Yanes, 
J., Andueza-Lilli, 
J., Gonzalez-
Ramallo, V., 
Pastor, L., Munoz, 
J.  
 
2006 
 
 
Medicine  
 
Observational 
study (only 2 
months long)   
 
A large university 
medical center ED 
(sees 515 
patients/day) 
 
Physicians in study 
Internal Medicine 
NOT EDMDs  
 
Compliance with 
EGDT guidelines 
poor, 
underestimated 
severe sepsis in 17 
patients while 
overestimated in 2 
patients.  
 
Huang, D., 
Clermont, G., 
Dremsizov, T., 
Angus, D. 2007 
 
 
Medicine 
 
Determine the 
estimated 
effectiveness and 
resource use when 
implement ting the 
SSC guidelines 
from the hospital 
perspective.  
 
1000 Simulated 
adult septic 
patients.  
 
Simulation of the 
average US ED.   
 
While there is 
financial 
investment in 
developing and 
implementing a 
process to initiate 
EGDT for sepsis 
patients the 
decreased length 
of stay and 
mortality rates can 
offset the initial 
costs.  
 
Jansen, T., van 
Bommel, J., 
Bakker, J.  
 
2009 
 
 
Medicine 
 
Systematic review 
of literature and 
Medical Database 
information.  
 
N/A 
 
Review 
determined that 
lactate plays a role 
in risk 
stratification for 
sepsis patients and 
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suggested further, 
more rigorous 
study of its use.    
 
Jones, A., Troyer, 
J., Kline, J.  
 
2011 
 
Medicine 
 
Economic data 
analysis.   
 
2 groups used the 
first one from 1 
year before EGDT 
was implemented 
and the 2nd from 2 
years after.  
 
Single center 
study. 
 
After very 
complex 
calculations it was 
determined that 
implementation 
EGDT is cost 
effective when 
calculating in the 
patient’s life 
expectancy and 
quality adjusted 
life years 
(QALYs).    
 
Jones, A., Shapiro, 
N., Roshon, M.  
 
2007 
 
 
 
Medicine 
 
Sepsis process 
implementation 
with pre and post 
process 
evaluations.  
 
Septic and septic 
shock patients 
admitted via the 
ED.  
 
3 large urban 
hospitals ED’s 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Each facility 
encountered its 
own set of 
challenges and 
barriers. The 
authors concluded 
that only an 
estimated 50% of 
ED patients in the 
US receive the 
recommended 
EGDT care for 
sepsis as 
healthcare 
providers are slow 
to accept these 
standards.  
Common 
conclusions 
included that each 
facility needed to 
use resources and 
staffing 
appropriate for 
their individual 
needs, each 
facilities medical 
staff both ED and 
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Intensive Care 
were slow to adopt 
EGDT,   the 
introduction of 
new equipment 
required extensive 
training time and 
availability was 
not consistently 
reliable. The 
necessary follow 
up to sustain the 
programs used a 
lot of resources 
and time.     
 
Lagu, T., 
Rothberg, M., 
Nathanson, B., 
Pekow, P., 
Steingrub, J., 
Lindenauer, P.  
 
2011 
 
Medicine 
 
Analyzed the 
amount of money 
spent by the 
facility on sepsis 
and compared to 
the mortality of the 
population.  
 
Between June 1. 
2004 to June 30, 
2006 reviewed 
166,931 septic 
patients’ records 
from 309 
hospitals. The 
majority of 
hospitals were in 
urban locations, 
half were in the 
southern US.      
 
The authors used 
complex data 
analysis and 
concluded there 
was NO 
relationship 
between spending 
more for sepsis 
care and improved 
patient outcomes.  
 
Lee, Chien-
Change, Chen, 
Shey-Ying, Tsai, 
Chu-Lin, Wu, 
Shwu-Chong, 
Chiang, Wen-Chu, 
Wange, Jiun-Ling, 
Sun, Hsin-Yun, 
Chen, Shyr-Chyr, 
Chen, Wen-Jone, 
Hsueh, Po-Ren 
 
2008 Taiwan 
 
Medicine 
 
Prospective 
observational 
study looking at 
the prognostic 
value of 
Procalcitonin, C-
Reactive protein 
and Mortality 
Scoring (MEDS) 
on septic ED 
patients.    
 
Consecutive ED 
patients meeting 
SIRS criteria who 
were >14 years 
old. 
 
Emergency 
department at a 
university 
affiliated facility 
seeing >110,000 
ED patients per 
year.  
 
The MEDS 
scoring was a 
predictor of 
mortality and 
Procalcitonin is 
better in predicting 
mortality than C-
Reactive Protein.  
 
Levy, M., 
Dellinger, P., 
Townsend, S., 
Zwirble, W., 
Marshall, J., Bion, 
 
Medicine  
 
A performance 
improvement 
initiative to look at 
sites using the SSC 
guidelines and the 
 
Any hospital 
worldwide 
participating in 
entering data into 
the SSC site.  
 
Impression: there 
is improving 
compliance with 
EGDT bundles and 
decreased 
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 Authors/Year Discipline Methods Sample/Setting Findings 
J., Schorr, C., 
Artigas, A., 
Ramsay, G., Beale, 
R., Parker, M., 
Gerlach, H., 
Reinhart, K., Silva, 
E., Harvey, M., 
Regan, S., Angus, 
D.  
 
2010  
facility mortality. 
 
Partnered with the 
Institute of 
Healthcare 
Improvement to 
develop bundles. 
 
165 hospitals in 30 
countries 
participated with a 
total of 15,022 
patients data 
included.   
mortality in septic 
patients. 
 
Reviewers stated 
this improvement 
may be secondary 
to the patients data 
entered into the 
site were not as 
seriously ill as 
protocol called for.   
 
Mikkelsen, M., 
Gaieski, D., Goyal, 
M., Miltiades, A., 
Munson, J., Pines, 
J., Fuchs, B., Shah, 
C., Bellamy, S., 
Christie, J.  
 
2010 
 
Medicine 
 
Retrospective 
cohort study of 
EGDT eligible 
patients via EMR 
review.  
 
2005 - 2007  
 
ED severe 
sepsis/septic shock 
patients in a 
University Based 
Hospital ED.   
 
EGDT was 
underutilized 
despite the 
documentation it 
improves patient 
outcomes.  
Analysis of 
EDMD’s showed 
that EGDT was 
less likely to be 
initiated when the 
MD was female 
and had practiced 
for years.  
 
EGDT not started 
42% of the time 
and not completed 
43% of the time. 
 
Nguyen, B. H., 
Corbett, S., Steele, 
R., Banta, J., 
Clark, R., Hayes, 
S., Edwards, J., 
Cho, T., Wittlake, 
W. 
 
2007 
 
Medicine 
 
2 year Prospective 
observational 
study.   
 
Academic medical 
center ED patients 
meeting severe 
sepsis/septic 
shock.    
 
A peer review 
forum used with 
the ED medical 
director sending 
letters to 
individual MD’s 
who did not 
complete the 
required EGDT 
bundle on eligible 
patients. It took 2 
years to reach 50% 
of implementation 
compliance.    
 
Powell, E., Khare, 
 
Medicine 
 
Cross-sectional 
 
National data 
 
The greater the 
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R., Courtney, M., 
Feinglass J. 
2010 
 
analysis of 2007 
national in-patient 
data.  
Healthcare 
Research and 
Quality Agency: 
healthcare cost 
utilization project. 
87,166 adult ED 
patients who were 
sepsis admits.  
From 551 US 
mainly urban 
hospitals.  
volume of sepsis 
the better the care 
the population 
received. Authors 
concluded 
increased volume 
equals improved 
quality of care 
secondary to 
experience.  
Shorr, A., Micek, 
S., Jackson, W., 
Kollef, M.  
 
2007 
 
 
Medicine 
 
Retrospective 
analysis of before 
and after a sepsis 
protocol 
implementation to 
determine the 
financial impact.  
120 ED patients 
with severe sepsis 
or septic shock, 
half before and 
half after sepsis 
protocol 
implementation.   
Academic hospital 
emergency 
department.    
The median cost 
per patient before 
the protocol was 
$21,985 and post 
protocol cost was 
$16,103. Use of 
the protocol not 
only saved live but 
also decreased 
overall hospital 
costs.  
 
Talmor, D., 
Greenberg, D., 
Howell, M., 
Lisbon, A., 
Novack, v., 
Shapiro, N. 
 
2008 
 
Medicine  
 
Prospective cohort 
study looking at 
both clinical and 
economic patient 
outcomes.  
 
Consecutive 
patients presenting 
in septic shock.  
 
Emergency 
Department and 
Intensive Care 
Units in an urban 
facility with a 
comprehensive 
sepsis protocol in 
place.   
 
The mortality of 
the historical 
control group was 
9.4% higher than 
the study group; 
however the costs 
associated to care 
for the study group 
was $8,807 higher 
than the historical 
control group.   
 
Vanzant, A., 
Schmelzer, M. 
 
2011 
 
Nursing  
 
Discussion of 
Sepsis and review 
of literature related 
to recognition and 
treatment of sepsis 
in the emergency 
department.    
 
N/A: Literature 
review and general 
discussion of 
sepsis.  
 
General review of 
Sepsis and the 
challenges faced 
by Emergency 
Departments in 
dealing with this 
patient population. 
Suggestion by the 
authors for ED’s to 
develop early 
recognition and 
treatment 
protocols.  
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Weinert, C., Mann, 
H.  
 
2008 
 
 
Medicine  
 
Opinion Review  
 
Purpose of review 
was to examine the 
lack of research 
being brought to 
the bedside.  
 
New discipline 
called 
Implementation 
Science was 
developed using 
principles from 
sociology, mass 
communications, 
adult education, 
informatics, 
research 
psychology and 
management 
theory. A new way 
to look at the 
evidence, confirm 
its strength and 
find a systematic 
way to change 
practice at the 
bedside mainly in 
the intensive care 
unit.  
 
 
Zubert, S., Funk, 
D., Kumar, A. 
 
2010 
 
Medicine 
 
Editorial  
 
Review of multiple 
studies looking at 
reducing mortality 
in septic patients 
using EGDT.  
 
Time is an 
important factor in 
the care of 
critically ill or 
injured patients. In 
the sepsis 
population 
receiving the most 
appropriate 
antibiotic within 
one of becoming 
symptomatic 
decreases 
mortality. 
Accomplishing 
this in a busy ED 
is challenging 
without an 
organized and 
systematic 
approach.  
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 Time Cohorts All Time 0 Time 1 Time 2 
Alert Status All Non-Alert Alert Non-Alert Alert Non-Alert 
Variables Number 
(%) 
Number 
(%) 
Number 
(%) 
Number 
(%) 
Number 
(%) 
Number 
(%) 
Size 201  
(100%) 
22 
(10.94%) 
19  
(9.45%) 
26  
(12.93%) 
113 
(56.21%) 
21  
(10.44%) 
Age 
      Range 
      Mean (sd) 
 
19-102 
62.42 
(18.47) 
 
23-90 
59.86 
(18.31) 
 
23 – 93 
62.37 
(20.78) 
 
19 – 88 
53.62 
(21.53) 
 
19 – 95 
64.95 
(16.66) 
 
29 – 102 
62.43 
(19.82) 
Gender 
      Male 
      Female 
 
103 (51.2) 
98 (48.8) 
 
9 (40.9) 
13 (59.1) 
 
14 (73.7) 
5 (26.3) 
 
17 (65.4) 
9 (34.6) 
 
57 (50.4) 
56 (49.6) 
 
6 (28.6) 
15 (71.4) 
Race 
     Caucasian 
     Black 
     Hispanic 
     Asian 
 
116 (57.7) 
60 (29.9) 
21 (10.4) 
4  (  2.0) 
 
14 (63.6) 
4 (18.2) 
3 (13.6) 
1 (4.5) 
 
13 (68.4) 
6 (31.6) 
0 (0.0) 
0 (0.0) 
 
14 (53.8) 
8 (30.8) 
4 (15.4) 
0 (0.0) 
 
65 (57.5) 
36 (31.9) 
10 (8.8) 
2 (1.8) 
 
10 (47.6) 
6 (28.6) 
4 (19.0) 
1 (4.8) 
Week Day 
    Sunday 
    Monday 
    Tuesday 
    Wednesday 
    Thursday 
    Friday 
    Saturday 
 
15 (  7.5) 
36 (17.9) 
33 (16.4) 
32 (15.9) 
32 (15.9) 
25 (12.4) 
28 (13.9) 
 
2 (9.1) 
6 (27.3) 
2 (9.1) 
2 (9.1) 
2 (9.1) 
7 (31.8) 
1 (4.5) 
 
0 (0.0) 
4 (21.1) 
4 (21.1) 
1 (5.3) 
6 (31.6) 
1 (5.3) 
3 (15.8) 
 
3 (11.5) 
4 (15.4) 
3 (11.5) 
6 (23.1) 
5 (19.2) 
1 (3.8) 
4 (15.4) 
 
9 (8.0) 
19 (16.8) 
24 (21.2) 
18 (15.9) 
14 (12.4) 
12 (10.6) 
17 (15.0) 
 
1 (4.8) 
3 (14.3) 
0 (0.0) 
5 (23.8) 
5 (23.8) 
4 (19.0) 
3 (14.3) 
Mode of 
Arrival 
    EMS 
    Private Car 
 
 
136 (67.7) 
65 (32.3) 
 
 
17 (77.3) 
5 (22.7) 
 
 
19 (100) 
0 (0.0) 
 
 
18 (69.2) 
8 (30.8) 
 
 
71 (62.8) 
42 (37.2) 
 
 
11 (52.4) 
10 (47.6) 
Shift Arrival 
7a-7p 
7p-7a 
 
127 (63.2) 
74 (36.8) 
 
13 (59.1) 
9 (40.9) 
 
12 (63.2) 
7 (36.8) 
 
17 (65.4) 
9 (34.6) 
 
69 (61.1) 
44 (38.9) 
 
16 (76.2) 
5 (23.8) 
Alert Status 
Alert 
Non-Alert 
 
132 (65.7) 
69 (34.4) 
 
0 (0.0) 
22 (100) 
 
19 (100) 
0 (0.0) 
 
0 (0.0) 
26 (100) 
 
113 (100) 
0 (0.0) 
 
0 (0.0) 
21 (100) 
C/O Systems 
    Metabolic 
    Neurologic 
    Respiratory 
    GI 
    Cardiac 
    
Skin/Wounds 
    GU   
 
56 (27.9) 
51 (25.4) 
31 (15.4) 
18 (9.0) 
12 (6.0) 
9 (4.5) 
3 (1.5) 
21 (10.4) 
 
4 (18.2) 
8 (36.4) 
5 (22.7) 
1 (4.5) 
3 (13.6) 
0 (0.0) 
0 (0.0) 
1 (4.5) 
 
6 (31.6) 
6 (31.6) 
3 (15.8) 
0 (0.0) 
0 (0.0) 
1 (5.3) 
0 (0.0) 
3 (15.8) 
 
4 (15.4) 
6 (23.1) 
4 (15.4) 
3 (11.5) 
2 (7.7) 
5 (19.2) 
0 (0.0) 
2 (7.7) 
 
38 (33.6) 
29 (25.7) 
13 (11.5) 
11 (9.7) 
7 (6.2) 
1 (0.9) 
2 (1.8) 
12 (10.6) 
 
4 (19.0) 
2 (9.5) 
6 (28.6) 
3 (14.3) 
0 (0.0) 
2 ( 9.5) 
1 (4.8) 
3 (14.3) 
102 
  
    Other 
WBC 
    Range 
    Mean 
 
0.5 – 84.5 
15.21 
(10.77) 
 
5.1 - 33.5 
15.84 
(9.49) 
 
0.5 – 54.0 
13.92 
(11.77) 
 
1.6 – 43.0 
15.66 
(10.91) 
 
0.5 – 84.4 
15.53 
(11.52) 
 
5.2 -25.9 
13.46 
(6.49) 
Antibiotic 
Order 
    Yes 
    No 
 
194 (96.5) 
7(  3.5) 
 
21 (95.5) 
1 (4.5) 
 
19 (100) 
0 (0.0) 
 
22 (84.6) 
4 (15.4) 
 
111 (98.2) 
2 (1.8) 
 
21 (100) 
0 (0.0) 
Lactate  
    Venous 
    Arterial 
    Not Done 
 
94 (46.8) 
69 (34.3) 
38 (18.9) 
 
5 (22.7) 
10 (45.5) 
7 (31.8) 
 
10 (52.6) 
8 (42.1) 
1 (5.3) 
 
6 (23.1) 
10 (38.5) 
10 (38.5) 
 
68 (60.2) 
38 (33.6) 
7 (6.2) 
 
5 (23.8) 
3 (14.3) 
13 (61.9) 
Lactate Level 
    Range 
    Mean (sd) 
 
0.0 – 48.0 
2.81 (4.26) 
 
0.0 - 8.4 
2.09 (.75) 
 
0.0 – 8.9 
1.53 (0.61) 
 
0.0 - 15.0 
3.05 (4.45) 
 
0.0 – 48 
3.15 (4.93) 
 
0.0 - 6.2 
1.14 (1.71) 
ED LOS 
    Range 
    Mean (sd) 
 
54 – 1772 
472.28 
(261.24) 
 
163 – 881 
442.18 
(182.70) 
 
127 – 793 
365.32 
(196.498) 
 
67 – 807 
422.88 
(202.92) 
 
54 – 1772 
487.81 
(280.38) 
 
173 -1442 
578.19 
(304.56) 
Hospital LOS 
    Range 
    Mean (sd)     
 
1 – 91 
10.11 
(11.19) 
 
1 – 60 
11.95 
(15.02) 
 
1 – 43 
9.00  
(9.27) 
 
1 – 43 
9.00  
(9.18) 
 
1 – 91 
10.48 
(11.82) 
 
1 – 21 
8.57  
(6.49) 
Discharge 
status 
    Home 
    SNF 
    Expired 
    Hospice 
    Home 
Health 
    Rehab 
    AMA 
    Psych 
 
66 (32.8) 
61 (30.3) 
42 (20.9) 
14 (7.0) 
12 (6.0) 
3 (1.5) 
2 (1.0) 
1 (0.5) 
 
6 (27.3) 
7 (31.8) 
5 (22.7) 
2 (9.1) 
2 (9.1) 
0 (0.0) 
0 (0.0) 
0 (0.0) 
 
2 (10.5) 
10 (52.6) 
6 (31.6) 
0 (0.0) 
0 (0.0) 
1 (5.3) 
0 (0.0) 
0 (0.0) 
 
9 (34.6) 
4 (15.4) 
9 (34.6) 
0 (0.0) 
3 (11.5) 
0 (0.0) 
1 (3.8) 
0 (0.0) 
 
41 (36.3) 
33 (29.2) 
21 (18.6) 
11 (9.7) 
3 (2.7) 
2 (1.8) 
1 (0.9) 
1 (0.9) 
 
8 (38.1) 
7 (33.3) 
1 (4.8) 
1 (4.8) 
4 (19.0) 
0 (0.0) 
0 (0.0) 
0 (0.0) 
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